<SEC-DOCUMENT>0001493152-25-017223.txt : 20251007
<SEC-HEADER>0001493152-25-017223.hdr.sgml : 20251007
<ACCEPTANCE-DATETIME>20251007090034
ACCESSION NUMBER:		0001493152-25-017223
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20251006
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251007
DATE AS OF CHANGE:		20251007

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bio Green Med Solution, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		251378338

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cyclacel Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20060329

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:BGMS="http://bgmsglobal.com/20251006">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_BGMS_bgmsglobal.com_20251006 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20251006_20251006 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001130166 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000004" name="dei:EntityCentralIndexKey">0001130166</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bgms-20251006.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-06</xbrli:startDate>
        <xbrli:endDate>2025-10-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BGMS:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-06</xbrli:startDate>
        <xbrli:endDate>2025-10-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BGMS:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-06</xbrli:startDate>
        <xbrli:endDate>2025-10-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_904_edei--DocumentType_c20251006__20251006_ziqLbOMduhO"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--DocumentPeriodEndDate_c20251006__20251006_zKriYCJ71EVi"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October
6, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (date of earliest event reported)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form8-k_001.jpg" alt="" style="height: 93px; width: 293px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90D_edei--EntityRegistrantName_c20251006__20251006_zdRyqHwaiTH9"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000011" name="dei:EntityRegistrantName">Bio
Green Med Solution, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20251006__20251006_zWtadun4XTEk"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20251006__20251006_zT0yQ3jA9dCi"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000013" name="dei:EntityFileNumber">0-50626</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20251006__20251006_zHbVdzNvGNX1"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000014" name="dei:EntityTaxIdentificationNumber">91-1707622</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20251006__20251006_zcT00i5yEiC5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000015" name="dei:EntityAddressAddressLine1">Level
10, Tower 11,</ix:nonNumeric> </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityAddressAddressLine2_c20251006__20251006_zoTRTjh6DLt"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000016" name="dei:EntityAddressAddressLine2">Avenue 5, No. 8</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine3_c20251006__20251006_zDb1XiuP4Utf"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000017" name="dei:EntityAddressAddressLine3">Jalan
Kerinchi</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20251006__20251006_zOnxtMYJw4oh"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000018" name="dei:EntityAddressCityOrTown">Kuala Lumpur</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCountry_c20251006__20251006_zUnZG36eKfr4"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt-sec:countrynameen" id="Fact000019" name="dei:EntityAddressCountry">Malaysia</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20251006__20251006_zvCqNLLX2xee"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000020" name="dei:EntityAddressPostalZipCode">59200</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--CityAreaCode_c20251006__20251006_z0yiyw6mxkYf"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000021" name="dei:CityAreaCode">(908)</ix:nonNumeric></span>
<span id="xdx_908_edei--LocalPhoneNumber_c20251006__20251006_zsWHGx3SBgD"><ix:nonNumeric contextRef="AsOf2025-10-06" id="Fact000022" name="dei:LocalPhoneNumber">517-7330</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20251006__20251006_zXEEgjX9zVUj"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20251006__20251006_z2dsF3GSPcVh"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20251006__20251006_zjzqT8o39vr1"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20251006__20251006_zxxSkgFeib36"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20251006__20251006__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zVOuWMtbkXyl"><ix:nonNumeric contextRef="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20251006__20251006__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_ztvMikvCYHPf"><ix:nonNumeric contextRef="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember" id="Fact000028" name="dei:TradingSymbol">BGMS</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_908_edei--SecurityExchangeName_c20251006__20251006__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zUW4BY8K9FJd"><ix:nonNumeric contextRef="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20251006__20251006__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zMT0etpiQlMk"><ix:nonNumeric contextRef="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember" id="Fact000030" name="dei:Security12bTitle">Preferred
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20251006__20251006__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_z9lOqE5o2jTj"><ix:nonNumeric contextRef="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember" id="Fact000031" name="dei:TradingSymbol">BGMSP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_904_edei--SecurityExchangeName_c20251006__20251006__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zxfF8QH2rBCj"><ix:nonNumeric contextRef="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_903_edei--EntityEmergingGrowthCompany_c20251006__20251006_zsYm4LUtgxf7"><ix:nonNumeric contextRef="AsOf2025-10-06" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Item
1.01 Entry into a Material Definitive Agreement.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2025, Bio Green Med Solution, Inc., a Delaware corporation (the &#8220;Company&#8221;) entered into an Asset Purchase Agreement
(the &#8220;Purchase Agreement&#8221;) with Tethra Biosciences Inc., a Delaware corporation (the &#8220;Buyer&#8221;). Under the terms
of the Purchase Agreement, the Company agreed to sell, and the Buyer agreed to purchase, certain assets, including all patent rights
(the &#8220;Assets&#8221;) of the Company related to Plogosertib, a polo-like kinase 1 (PLK 1) inhibitor for treatment of advanced cancers
and hematological malignancies (&#8220;Plogo&#8221;), for a purchase price of $300,000, plus a further potential Milestone (as defined
in the Purchase Agreement) of $170,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations, warranties and covenants. The sale of the Assets pursuant to the Purchase Agreement
was consummated on October 6, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the material terms of the Purchase Agreement does not purport to be complete and is qualified in its entirety
by reference to the full text of such agreement, a copy of which is attached hereto as Exhibit 2.1 and is incorporated herein in its
entirety by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Item
2.01. Completion of Acquisition or Disposition of Assets.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Item
9.01. Financial Statements and Exhibits</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex2-1.htm">Asset Purchase Agreement dated October 6, 2025 by and between Bio Green Med Solution, Inc., and Tethra Biosciences Inc.</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                                         confidential portions of this Exhibit were omitted by means of marking such portions with brackets (&#8220;[****]&#8221;) because
                                                         the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    October 7, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bio
    Green Med Solution, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Datuk Dr. Doris Wong Sing Ee</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Executive Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kU1ugzAQRk+QO4xQlxExVMmCXYvSqCqpEImibp0waa2AB40NTY7UW9aYQjetZcmy/b15/gmCebChJ1Uhw9tjkcEe66aSFqHAMzLqE7pE+vySgBsLfFfGstTWT0cwJcegY1ZhfHTrPtkpg2UCkViI1SJegoiS5T3k22DW76ekz6pEbZWsQOoScqaGFVrJt6HCXl5JU33zpgOyUaRduVAM218QiyiGV+rkJ/HFQJalwWzu2yzYMLWNS62vFnVPwrrC2unMQP92f5pTayzVSc79nRnLnaXTRYRCRLnkg6xa3GJ9RHbRSMRxJB5+TjER4JE53HkKGsnQ9dwfFvdaNWmfH6sPKuTdh+T/VAM2eibBZHT/YHp8NH4Do36K8w== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[****]
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not
material and would likely cause competitive harm if publicly disclosed.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSET
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>by
and between</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIO
GREEN MED SOLUTION, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TETHRA
BIOSCIENCES INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dated
as of October 6, 2025 </B><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    I TRANSFER OF PROPERTIES AND ASSETS OF SELLER</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 0.5in">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    and Transfer of Properties and Assets.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">1</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded
    Assets.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">2</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    Obligations.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">3</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded
    Obligations.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">3</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    Price.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">3</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding
    of Taxes.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">3</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
    Closing Deliveries.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">3</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
    Closing Deliveries.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">4</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tangible
    Purchased Assets; Assigned Books and Records.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">5</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    II REPRESENTATIONS AND WARRANTIES OF SELLER</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Organization, Standing and Power.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">6</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consents,
    Authorization and Enforceability.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">6</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    to Assets; Sufficiency of Assets.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">6</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Contravention.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">6</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
    and Commitments.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">7</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">7</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">8</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.8</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
    with Law.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
                                            2.10</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Location
                                            of Purchased Assets.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
    for the Compound.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">9</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    III [INTENTIONALLY OMITTED]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    IV REPRESENTATIONS AND WARRANTIES OF BUYER</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">9</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization,
    Standing and Authority.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">9</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consents
    and Authorization.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">9</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Contravention.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">9</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation
    and Claims.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">10</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    V COVENANTS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
    to Information.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom">10</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
    of Confidentiality and Non-Use.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
    Assurances.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncompetition.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
    Inquiries.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    VI MISCELLANEOUS.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival
    of Representations and Warranties and Covenants.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    Law; Jurisdiction.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver
    of Jury Trial.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments;
    Expenses.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire
    Agreement.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    and Modification.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Binding
    Effect; Benefits.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignability.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation
    Provisions.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific
    Performance; Equitable Remedies.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.1</FONT>5</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
    of Party&rsquo;s Affiliates.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedules:</B></FONT></P>



<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 1.1</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
    &ndash; Purchased IP</FONT></TD>
    <TD STYLE="text-align: right; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Schedule 1.1 (b) &ndash; Regulatory Filings and Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Schedule 1.1 (d) &ndash; Purchased Inventory</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 1.7 (d) &ndash; Consents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits:</B></FONT></P>



<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    A &ndash;</FONT> Bill of Sale and Assignment</FONT></TD>
    <TD STYLE="text-align: right; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    B &ndash; Patent Assignment</FONT>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    C &ndash;</FONT> Compound</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    D &ndash;</FONT> Information for the Compound</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSET
PURCHASE AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
ASSET PURCHASE AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of October 6, 2025, by and between Bio Green Med Solution,
Inc. (f/k/a Cyclacel Pharmaceuticals, Inc.), a Delaware corporation (together, &ldquo;<B>Seller</B>&rdquo;) on the one hand, and Tethra
Biosciences Inc., a Delaware corporation (&ldquo;<B>Buyer</B>&rdquo;) on the other hand. Hereinafter, &ldquo;<B>Parties</B>&rdquo; shall
mean Seller and Buyer together, and &ldquo;<B>Party</B>&rdquo; shall mean either Seller or Buyer, as the context requires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Seller desires to sell, transfer, convey, assign and deliver to Buyer, and Buyer desires to purchase and acquire from Seller, certain
assets and rights of Seller and its Affiliates related to the Compound or Products (hereinafter defined), on the terms set forth in this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, Buyer and Seller hereby
agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRANSFER
OF PROPERTIES AND ASSETS OF SELLER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.1 <U>Sale and Transfer of Properties and Assets</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the terms and subject to the conditions of this Agreement, Buyer shall purchase and acquire, and Seller shall sell, transfer, convey,
assign and deliver to Buyer, free and clear of all mortgages, pledges, charges, hypothecations, liens, claims, security interests and
encumbrances of any kind, nature or description (collectively, &ldquo;<B>Liens</B>&rdquo;) (except as expressly permitted in this Agreement
and except for Permitted Liens), at the closing (the &ldquo;<B>Closing</B>&rdquo;), all right, title and interest of Seller in and to
the following assets and rights (collectively, the &ldquo;<B>Purchased Assets</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
all of Seller&rsquo;s right, title and interest in, to and under the Purchased IP, including the Patent rights listed on <U>Schedule
1.1(a)</U>, including all rights to recover for past infringement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
all Regulatory Filings and Approvals to the extent related to the Compound, including the Regulatory Filings and Approvals set forth
on <U>Schedule 1.1(b)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
all intangibles and goodwill of Seller arising from the Purchased IP or any of the other Purchased Assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
all Inventory of the Compound or Products, including the Inventory listed on <U>Schedule 1.1(d)</U> (the &ldquo;<B>Purchased Inventory</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
all books, records, files, manuals, and other documentation (including clinical study reports, investigator brochures, and laboratory
books), or portion thereof, in the possession or Control of Seller or its Affiliate to the extent relating to the Compound or Products,
including (i) all data in all databases for all clinical and pre-clinical studies (if any) for all drug trials undertaken in connection
with the Compound, Clinical Trials, CMC, CRF, CRO, CSR, DSMB, DSUR, ECs, IB, ICF, IMP, IRB, MAA, PSUR, SAP, SOP, SOW, TLF, and TMF; (ii)
all Purchased IP files, file histories and other technical documents and correspondence, and (iii) all business information, tangible
or intangible, to the extent relating to the Compound or Products, including supplier and distributor lists related to the Compound or
Products (the &ldquo;<B>Assigned Books and Records</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
all claims (including claims for past infringement or misappropriation of the Purchased IP), causes of action, judgments and demands
of whatever kind or description, or portion thereof (regardless of whether or not such claims and causes of action have been asserted
by Seller), to the extent relating to any of the Purchased Assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
all equipment related to the Purchased Assets; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
any other assets owned or controlled by Seller or its Affiliates related primarily to the Compound or the Product that are, in the sole
discretion of Buyer, necessary or reasonably useful for the conduct of the Business following the Closing, or to research, Develop, Manufacture
or Commercialize the Compound or any Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, Buyer is not purchasing any Contract from Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.2 <U>Excluded Assets; Consents; Wrong Pockets</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
assets, properties, rights and interests of Seller not included in the Purchased Assets and separately, any Purchased Asset that may
not be assigned to Buyer without the written consent of a Third Party which has not been obtained prior to the Closing (any such Purchased
Asset, a &ldquo;<B>Deferred Item</B>&rdquo;) are expressly excluded from the purchase and sale contemplated hereby until such time as
such consent to any Deferred Item is obtained, and as such are not included in the Purchased Assets and shall remain the assets, property
rights and interests of Seller until such time as such consent to any Deferred Item is obtained (collectively, the &ldquo;<B>Excluded
Assets</B>&rdquo;), provided that Seller shall, with respect to each Deferred Item, (i) use good faith diligent efforts to obtain the
relevant consent as promptly as practicable after the Closing, and (ii) until such consent is obtained, make the benefits under such
Deferred Item available to Buyer. In the event that a consent that is required for the assignment or transfer of any of the Purchased
Assets is not obtained prior to the Closing, then Buyer and Seller shall, if requested by Buyer, enter into such arrangements (including
subleasing or subcontracting if permitted) to provide to the Parties hereto substantially the same economic and operational equivalent
of obtaining such consent and assigning or transferring such Purchased Asset, including the authorization, license or permit, or enforcement
by Seller for the benefit of Buyer of all claims or rights arising thereunder, and the performance by Buyer of the obligations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
after the Closing, Buyer or any of its Affiliates possesses any Excluded Asset, Buyer shall, or shall cause its Affiliates to, transfer
such asset to Seller at no cost to Seller. If, after the Closing, Seller or any of its Affiliates possesses any Purchased Asset, Seller
shall, or shall cause their Affiliates to, transfer such asset to Buyer at no cost to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.3 <U>Assumed Obligations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the terms and subject to the conditions of this Agreement, at the Closing, Buyer shall assume and, from and after the Closing, shall
pay, perform, satisfy and discharge (or cause to be paid, performed, satisfied and discharged on behalf of Buyer) when due, (i) all obligations
of Seller to be performed on or after the Closing pursuant to the Purchased Assets, (ii) all Liabilities arising out of or relating to
the Development, Manufacture or Commercialization of the Compound or a Product on or following the Closing, and otherwise (iii) all Liabilities
arising on or after the Closing with respect to the Purchased Assets (collectively, the &ldquo;<B>Assumed Obligations</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4 <U>Excluded Obligations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, the Assumed Obligations do not include any obligations whatsoever not expressly assumed by
Buyer under Section 1.3 (collectively, the &ldquo;<B>Excluded Obligations</B>&rdquo;), including without limitation, (i) any transaction
costs of Seller incurred in relation to the asset transfer carried out pursuant to this Agreement, (ii) any Indebtedness of Seller, (iii)
any Retained Tax Liabilities, (iv) any Seller Employees Liabilities, (v) subject to Section 1.3, any Liability arising from or relating
to the Purchased Assets other than Assumed Obligations under the Purchased Assets on or after the Closing, (vi) any obligation or liability
under any of Seller&rsquo;s Contracts, and (vii) all other Liabilities or Losses arising out of or relating to the Development, Manufacture
or Commercialization of the Compound, Product or Purchased Assets prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.5 <U>Purchase Price</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the terms and subject to the conditions of this Agreement, in consideration for the sale, conveyance, assignment, transfer and delivery
of the Purchased Assets, Buyer agrees to (i) assume the Assumed Obligations at the Closing and (ii) make the following payments (the
foregoing items (i) and (ii) collectively, the &ldquo;<B>Purchase Price</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Initial
                                            Payment</U>. At Closing, Buyer shall pay to Seller the amount of three hundred thousand dollars
                                            and (US$300,000) (the &ldquo;<B>Initial Payment</B>&rdquo;).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Milestone
                                            Payment</U>. Upon initial dosing of the first patient in a Phase 2 Clinical Trial for the
                                            Compound (the &ldquo;<B>Milestone</B>&rdquo;), Buyer shall, within sixty (60) days of the
                                            achievement of the foregoing Milestone, pay to Seller an additional one hundred and seventy
                                            thousand dollars (US$170,000). Buyer shall provide notice of the Milestone within thirty
                                            (30) days following the achievement of the Milestone.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-align: justify; text-indent: -.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.6 <U>Withholding of Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
shall be entitled to deduct and withhold from any amounts payable or otherwise deliverable pursuant to this Agreement to Seller such
amounts as may be required to be deducted or withheld therefrom under any provision of federal, state, local or foreign Tax law or under
any Applicable Laws. To the extent such amounts are so deducted and withheld, such amounts shall be treated for all purposes under this
Agreement as having been paid to Seller. Each Party shall cooperate and otherwise take commercially reasonable efforts to obtain appropriate
exemptions for or refunds of any such applicable Taxes and to minimize any such Taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.7 <U>Seller Closing Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
shall deliver to Buyer at the Closing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
a bill of sale, dated the Closing Date, substantially in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Bill of Sale</B>&rdquo;),
duly executed by Seller;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
a patent assignment agreement, dated the Closing Date, substantially in the form attached as <U>Exhibit B</U> (the &ldquo;<B>Patent Assignment</B>&rdquo;),
duly executed by Seller;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
An IRS Form W-9 duly executed by Seller (or Seller&rsquo;s owner, if Seller is a disregarded entity for U.S. federal income tax purposes)
certifying that Seller is a U.S. person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Evidence that all the consents set forth in Schedule 1.7(d) have been obtained or made, as applicable (the &ldquo;<B>Required Consents</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
evidence of payment of all outstanding legal fees and costs related to the Patents included within the Purchased IP, in each case, to
the extent arising prior to June 30, 2025; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
such other customary instruments of transfer, assumptions, filings or documents as Buyer may reasonably request to give effect to this
Agreement or any of the Purchase Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, subject to Seller&rsquo;s compliance with Section 5.3(c), the failure by Seller to obtain the consent
of any Third Party to the assignment of any contract prior to Closing other than a Required Consent shall not be a breach of Seller&rsquo;s
obligations under this Section 1.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.8 <U>Buyer Closing Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
shall deliver to Seller at the Closing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the Bill of Sale, as duly executed by Buyer; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the Initial Payment in immediately available funds transferred to a Seller bank account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evidence of payment of all outstanding legal fees and costs related to the Patents included within the Purchased IP, in each case, to the extent arising on or after June 30, 2025 and as set forth on Schedule 1.8(c).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .25in; text-align: justify; text-indent: -.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.9 <U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Closing will take place on the date hereof (the &ldquo;<B>Closing Date</B>&rdquo;). The Closing shall be effective as of 12:00:01
a.m. Eastern Time on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The obligations of Buyer to consummate the transactions contemplated by this Agreement are subject to the following conditions, except
to the extent waived by Buyer in writing at the Closing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
All representations and warranties of Seller contained in this Agreement shall be accurate, true and correct in all respects as of the
Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Seller shall have delivered to Buyer the documents set forth in Section 1.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Seller shall have delivered or made available (with download rights) to Buyer true, accurate, correct and complete copies of the documents
set forth in <U>Exhibit D</U> that are in Seller&rsquo;s possession or control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
There shall not have been instituted or threatened any legal proceeding (A) relating to, or seeking to prohibit or otherwise challenge
this Agreement, the Bill of Sale or the Patent Assignment (collectively, the &ldquo;<B>Purchase Agreements</B>&rdquo;), the consummation
of the transactions contemplated by any of the Purchase Agreements, or seeking to obtain substantial damages with respect to any of the
Purchase Agreements, or (B) which would reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
There shall not have been any action taken, or any law, rule, regulation, order, judgment, or decree proposed, promulgated, enacted,
entered, enforced, or deemed applicable to the transactions contemplated by any of the Purchase Agreements, by any federal, state, local,
or other governmental authority or by any court or other tribunal, including the entry of a preliminary or permanent injunction, which
would reasonably be expected to: (A) make any of the transactions contemplated by any of the Purchase Agreements illegal or (B) impose
material limitations on the ability of Buyer to operate the Business after the Closing or to exercise full rights of ownership of the
Purchased Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
There shall not have occurred any Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
Seller shall have delivered to Buyer, at or prior to the Closing, such other documents as Buyer shall have reasonably requested to carry
out the provisions of and the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The obligations of Seller to consummate the transactions contemplated by this Agreement are subject to the following conditions, except
to the extent waived by Seller in writing at the Closing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
All representations and warranties of Buyer contained in this Agreement shall be accurate in all material respects as of the Closing
with the same effect as if made on and as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Buyer shall have delivered to Seller the documents set forth in Section 1.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
There shall not have been instituted or threatened in writing any legal proceeding (A) relating to, or seeking to prohibit or otherwise
challenge the Purchase Agreements, the consummation of the transactions contemplated by any of the Purchase Agreements, or seeking to
obtain substantial damages with respect to any of the Purchase Agreements, or (B) which would reasonably be expected to have a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
There shall not have been any action taken, or any law, rule, regulation, order, judgment, or decree proposed, promulgated, enacted,
entered, enforced, or deemed applicable to the transactions contemplated by any of the Purchase Agreements, by any federal, state, local,
or other governmental authority or by any court or other tribunal, including the entry of a preliminary or permanent injunction, which
would reasonably be expected to make any of the transactions contemplated by any of the Purchase Agreements illegal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.10 <U>Tangible Purchased Assets; Assigned Books and Records</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Seller shall, without charge to Buyer, hold all tangible Purchased Assets (other than tangible Purchased Assets that are held on behalf
of any Seller by any Third Party) on behalf of Buyer until such time or times that Buyer or its designees takes possession thereof; provided,
however, that Buyer or its designees shall take possession of all tangible Purchased Assets no later than the date that is ten (10) days
after the Closing. With respect to tangible Purchased Assets held by any Third Parties on behalf of Seller, Seller shall cause, or assist
Buyer for, such Third Parties to continue to hold such tangible Purchased Assets on behalf of Buyer at Buyer&rsquo;s expense, and shall
maintain proper insurance for the replacement value of such Purchased Assets, at Buyer&rsquo;s expense, until Buyer takes possession
of such Purchased Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to <U>Section 5.1</U>, Seller may retain copies of any Assigned Books and Records to the extent necessary for tax, accounting,
regulatory, compliance or litigation purposes, or to perform and discharge the Excluded Obligations and their obligations under this
Agreement, or if such Assigned Books and Records contain information with respect to any Excluded Asset or Excluded Obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES OF SELLER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
hereby represents and warrants to Buyer as follows, with each such representation and warranty subject only to such exceptions, if any,
as are set forth on that section of the written disclosure schedules dated as of the date hereof delivered by Sellers to Buyer (the &ldquo;<B>Seller
Disclosure Schedule</B>&rdquo;) that is numbered and captioned to correspond to, and is referenced in, such representation or warranty:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.1 <U>Corporate Organization, Standing and Power</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
is a company duly organized, validly existing and in good standing under the laws of Delaware. Seller has all necessary corporate power
and authority to execute and deliver this Agreement and the other Purchase Agreements to which it is a party and to perform its obligations
hereunder and thereunder. Seller has all requisite corporate power and authority to carry on its Business as now being conducted in relation
to the Purchased Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.2 <U>Consents, Authorization and Enforceability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No consent, waiver, approval, order or authorization of, or registration, declaration or filing with, or notice to any Governmental Authority
or other Third Party is required by, or with respect to, Seller or the Purchased Assets in connection with the execution and delivery
of this Agreement or the other Purchase Agreements to which it is a party, the performance by Seller of its obligations under this Agreement
or the other Purchase Agreements, or the consummation of the transactions contemplated hereby or thereby, except such consents, waivers,
approvals, authorizations, registrations, declarations, filings or notices, the absence of which, would not, individually or in the aggregate,
have or reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All requisite corporate action necessary to authorize the execution, delivery and performance by Seller of this Agreement and the other
Purchase Agreements to which it is a party and the consummation of the transactions contemplated hereby and thereby has been taken. This
Agreement constitutes a valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, except as may
be limited by bankruptcy, insolvency, reorganization, moratorium, arrangement or other similar Applicable Law or equitable principles
relating to or limiting creditors&rsquo; rights generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.3 <U>Title to Assets; Sufficiency of Assets</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
has good, valid and marketable title to all of the Purchased Assets. Seller holds all of the Purchased Assets free and clear of all Liens
except for: (a) mechanics&rsquo;, materialmen&rsquo;s, carriers&rsquo;, workmen&rsquo;s, warehousemen&rsquo;s, repairmen&rsquo;s, landlords&rsquo;
or other like Liens and security obligations incurred in the ordinary course of business for immaterial amounts, and (b) statutory liens
for Taxes, assessments or other statutory or governmental charges not yet due and payable and for which adequate reserves have been established
(collectively, &ldquo;<B>Permitted Liens</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.4 <U>Non-Contravention</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
execution and delivery by Seller of this Agreement and the other Purchase Agreements to which it is a party, the performance by Seller
of its obligations hereunder and thereunder, and the consummation of the transactions contemplated hereby and thereby, do not and will
not (a) violate any provision of the certificate of incorporation or similar constitutional documents of Seller, (b) result in a breach
(or any event which, with notice or lapse of time or both, would constitute a breach) of any term or provision of, or constitute a default
under, any Contract to which Seller is a party or by which it is bound, (c) result in the creation of any Lien on the Purchased Assets
(other than a Permitted Lien) or (d) violate in any respect any Applicable Law or any judgment, decree, order, regulation or rule of
any Governmental Authority by which Seller is bound or subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.5 <U>Contracts and Commitments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
has made available to Buyer copies of Contracts and/or work orders that are related to the Compound, the Product or the Business that
are in its possession, as listed on <U>Schedule 2.5</U> and, to the Knowledge of Seller, each such Contract is valid and binding on the
Seller that is a party thereto in accordance with its terms and is in full force and effect. There is not under any Contract: (a) any
existing material default by such Seller or, to Seller&rsquo;s Knowledge, by any other party thereto; or (b) any event which, after notice
or lapse of time or both, would constitute a material default by such Seller or, to Seller&rsquo;s Knowledge, by any other party, or
result in a right to accelerate or terminate or result in a loss of any rights of Seller. To Seller&rsquo;s Knowledge, there are no Contracts
to which Seller or any of its Affiliates is a party pursuant to which Seller in-licenses intellectual property rights exclusively related
to the Compound or any Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.6 <U>Intellectual Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Schedule 1.1(a)</U> sets forth a complete and accurate list of all Patent rights owned or in-licensed by Seller relating exclusively
to the Compound or any Product that the manufacture, use, sale, offer for sale or importation of the Compound or any Product would infringe,
specifying as applicable: (i) the title thereof, if any; (ii) the registration or application number thereof, if any; and (iii) the jurisdiction
in which such item exists or is registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All Purchased IP is exclusively owned by Seller, and is free and clear of any (i) liens, charges, security interests, and encumbrances
or licenses and (ii) claims or covenants that would give rise to any Third Party claims for payment against Buyer. Neither Seller nor
any of its Affiliates has entered into any agreement or otherwise licensed, granted, assigned, transferred, conveyed or disposed of any
right, title or interest in or to any of its assets, including any intellectual property rights or the Compound or any Product, that
would conflict with or impair the scope of any rights within the Purchased IP or licenses granted hereunder. None of Seller or any of
its Affiliates is a party to any license, sublicense or other agreement pursuant to which Seller or such Affiliate has received a license
or other rights relating to any Compound or Product. There are no agreements to which any Seller is a party pursuant to which any Seller
has granted any Third Party any rights in and to any Purchased IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
There are no claims pending or, to Seller&rsquo;s knowledge, threatened in writing against any Seller or before any Governmental Authority,
challenging the validity of any Patents within the Purchased IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Patents listed on Schedule 1.1(a) have been duly applied for and registered in accordance with applicable Law, and the Seller have
paid, or caused to be paid, all filing fees, issue fees, annuities and other fees and charges applicable to the Purchased IP, including
those required for the issuance, registration, maintenance, filing and prosecution of the Purchased IP. No Purchased IP is the subject
of any pending or, to Seller&rsquo;s knowledge, threatened interference, opposition, cancellation, protest, litigation or other challenge
or Action. To Seller&rsquo;s knowledge, the Seller and their patent counsel have satisfied statutory requirements with respect to the
filing, prosecution, and maintenance of all registered Purchased IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
To Seller&rsquo;s Knowledge, Seller have secured from all employees, consultants, contractors and other Persons who have contributed
to the creation or invention of any of the Purchased IP a written agreement setting forth obligations of confidentiality and assigning
to Seller or its Affiliates all rights to such creations, inventions, and Purchased IP, and such Affiliates have assigned all such rights
to Seller or its Affiliates. Seller not has received any written communication from any Third Party challenging any Seller&rsquo;s ownership
of or right to use the Purchased IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
To Seller&rsquo;s Knowledge, no Person has infringed, misappropriated, or otherwise violated, and no Person is currently infringing,
misappropriating, or otherwise violating, any claim of an issued (granted) and unexpired Patent within the Purchased IP, or has misappropriated
any Know-how within the Purchased IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
To Seller&rsquo;s Knowledge, no Action has been instituted by any Third Party or is pending against any Seller or has been threatened
by any Third Party in writing that (i) challenges the right of any Seller with respect to its use or ownership of the Purchased IP, or
(ii) alleges that any of the issued claims included in the Patents within the Purchase IP are invalid or unenforceable, or that Development
or Manufacture of the Purchased IP, Compound or any Product infringed or misappropriated, or would infringe or misappropriate, the intellectual
property rights of such Third Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Seller has furnished or made available to Buyer all material information that is in the possession of Seller or any of its Affiliates
concerning the Purchased IP, the Compound or any Product relevant to the safety or efficacy thereof, and all material Regulatory Filings
and Approvals and other material correspondence with Regulatory Authorities relating to the Compound or any Product, and, to Seller&rsquo;s
Knowledge, such information is accurate, complete and true in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.7 <U>Litigation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as set forth on Schedule 2.7(a), there is no action, cause of action, suit, claim, charge, demand, directive, inquiry, subpoena,
proceeding, arbitration, mediation or other investigation (collectively, &ldquo;<B>Actions</B>&rdquo;) pending or, to Seller&rsquo;s
Knowledge, threatened against any Seller or any predecessor in interest to any Seller (i) relating to or affecting the Purchased Assets
or the Assumed Obligations, (ii) relating to or seeking to prevent Seller&rsquo;s performance of this Agreement, the Purchase Agreements
and the transactions contemplated hereby, (iii) that would reasonably be expected to adversely affect the Development, Manufacture or
Commercialization of the Compound or any Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
None of the Purchased Assets is subject to any order, writ, judgment, award, injunction or decree of any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.8 <U>Compliance with Law</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Seller have conducted, and are now conducting, their businesses as applied to or in connection with the Purchased Assets in compliance
in all material respects with Applicable Laws. Neither Seller nor any of its Affiliates has received any notice alleging any violation
under any Applicable Law with respect to the Purchased Assets or the Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
To Seller&rsquo;s Knowledge, no Seller has employed or used any person that has been debarred, excluded or disqualified under Section
306(a) or 306(b) of the U.S. Federal Food, Drug and Cosmetic Act in the Development of any Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
To Seller&rsquo;s Knowledge, Seller have conducted all clinical and pre-clinical studies for all drug trials undertaken in connection
with the Compound or any Product in accordance with applicable Health Care Laws and no Seller has received any notice from a Governmental
Authority alleging any violation under any applicable Health Care Law or requiring the termination, suspension or material modification
of such clinical or pre-clinical studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.9 <U>Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no Liens for Taxes on any of the Purchased Assets (other than Permitted Liens) and to Seller&rsquo;s Knowledge, there are no Taxes
of Seller related to the Purchased Assets which could become liabilities of Buyer. None of the Purchased Assets constitutes a &ldquo;United
States real property interest&rdquo; for federal income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.10 <U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.11 <U>Information for the Compound</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, Seller shall provide or make available to Buyer the information set forth in <U>Exhibit D</U> that are in Seller&rsquo;s
possession or control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[INTENTIONALLY
OMITTED]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES OF BUYER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
hereby represents and warrants to Seller as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.1 <U>Organization, Standing and Authority</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. Buyer has all necessary
corporate power and authority to execute and deliver this Agreement and the other Purchase Agreements to which it is a party and to perform
its obligations hereunder and thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.2 <U>Consents and Authorization</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No consent, waiver, approval, order or authorization of, or registration, declaration or filing with, or notice to any Governmental Authority
or other Third Party is required by, or with respect to, Buyer in connection with the execution and delivery of this Agreement or the
other Purchase Agreements to which it is a party or the consummation of the transactions contemplated hereby or thereby, except for any
notice filings or registrations of transfer with any Governmental Authority that may be required in connection with the assignment and
transfer of the Purchased Assets, and such other consents, waivers, approvals, authorizations, registrations, declarations, filings or
notices, the absence of which, would not, individually or in the aggregate, have or reasonably be expected to have a materially adverse
effect on the ability of Buyer to consummate the transactions contemplated hereby (a &ldquo;<B>Buyer Material Adverse Effect</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All requisite corporate action necessary to authorize the execution, delivery and performance by Buyer of this Agreement and the other
Purchase Agreements to which it is a party and the consummation of the transactions contemplated hereby and thereby has been taken. This
Agreement constitutes a valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms, except as may
be limited by bankruptcy, insolvency, reorganization, moratorium, arrangement or other similar Applicable Law or equitable principles
relating to or limiting creditors&rsquo; rights generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.3 <U>Non-Contravention</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
execution and delivery by Buyer of this Agreement and the other Purchase Agreements to which it is a party, the performance by Buyer
of its obligations hereunder and thereunder, and the consummation of the transactions contemplated hereby and thereby, do not and will
not (a) violate any provision of the certificate of incorporation or similar governance documents that may be applicable to Buyer, (b)
result in the breach (or an event which, with notice or lapse of time or both, would constitute a breach) of any term or provision of,
or constitute a default under any Contract to which Buyer is a party or by which it is bound or (c) violate in any respect any Applicable
Law or any judgment, decree, order, regulation or rule of any Governmental Authority to which Buyer is bound or subject, except, with
respect to the immediately preceding clauses (b) and (c), for any violations, breaches or defaults that would not, individually or in
the aggregate, have a Buyer Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.4 <U>Litigation and Claims</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no Action pending, or to the Knowledge of Buyer, threatened, against Buyer before or by any Governmental Authority which seeks to
prevent Buyer&rsquo;s performance of this Agreement and the transactions contemplated hereby or that would, individually or in the aggregate,
have a Buyer Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.5 <U>Financing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
has a reasonable basis to believe that it will obtain financing sufficient to fund the Development and Commercialization of a Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COVENANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.1 <U>Access to Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
For so long as a Party maintains books, records, files and other information that is subject to this <U>Section 5.1</U>, during normal
business hours following reasonable prior notice, such Party will permit the other Party and its accountants, counsel, and other representatives,
subject to the obligations set forth in <U>Section 5.2</U> of this Agreement, to have reasonable access to and examine and make copies
of all Assigned Books and Records and all other books and records of a Party which are reasonably requested by the other Party and are
necessary or useful in connection with: (i) any Tax inquiry, audit, investigation or dispute with a Third Party; (ii) any Action by any
Governmental Authority or any dispute with any Third Party reasonably requiring access to any such books and records; or (iii) with respect
to Buyer, the Development, Manufacture or Commercialization of the Product, in each case relating to or arising out of transactions or
events occurring prior to the Closing and that relate to the Purchased Assets. The Party requesting access to any such Assigned Books
and Records or Seller&rsquo; retained books and records or other information shall bear all of the out of pocket costs and expenses (including
attorneys&rsquo; fees, but excluding reimbursement for salaries and employee benefits) reasonably incurred in connection with providing
access to and copies of such Assigned Books and Records, Seller&rsquo; retained books and records or other information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Buyer and Seller will direct their respective employees (without substantial disruption of employment) to render any assistance that
Buyer or any Seller may require in examining or utilizing the Assigned Books and Records.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Neither Buyer nor any Seller will destroy any books, records, files or other information or data that are subject to this <U>Section
5.1</U> until the expiration of the applicable regulatory record retention period under Applicable Laws (giving effect to any and all
extensions or waivers) without giving at least thirty (30) days&rsquo; prior written notice to the other Party (the &ldquo;<B>Retaining
Party</B>&rdquo;). Upon receipt of such notice, the Retaining Party may (i) cause to be delivered to it the books and records intended
to be destroyed, at its expense or (ii) notify the Party intending to destroy the books and records that it will pay the cost of storing
and maintaining such books and records (including any necessary costs of moving such books and records to a location under control of
the Retaining Party and the costs of reviewing and removing from such books and records any information that the Retaining Party is not
entitled to receive).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Buyer and Seller will keep all information referred to in this <U>Section 5.1</U> confidential in accordance with <U>Section 5.2</U>
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
For a period of sixty (60) days after the Closing, Seller shall, at the reasonable request of Buyer, provide to Buyer, or give access
to Buyer, any Contract (to the extent not already provided as set forth in <U>Section 2.5</U> above) or information or document that
is related to the Compound or the Product that is in the possession of Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Seller shall, within five (5) business days after the Closing, (i) notify Theradex Systems, Inc. (&ldquo;<B>Theradex</B>&rdquo;) of this
Agreement and the transactions contemplated thereby, (ii) introduce Buyer (email being sufficient) to Theradex with respect to Seller&rsquo;s
files at Theradex, including all Regulatory Filings and Approvals made by Theradex on behalf of Seller with respect to the Compound or
the Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.2 <U>Obligations of Confidentiality and Non-Use</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each Party agrees that the Party receiving or otherwise possessing Confidential Information (the &ldquo;<B>receiving Party</B>&rdquo;)
from the other Party (the &ldquo;<B>disclosing Party</B>&rdquo;), pursuant to this Agreement shall, and shall cause its employees, directors,
officers, contractors, consultants, service providers and other representatives to, keep confidential and not publish or otherwise disclose,
and take all reasonable steps to prevent disclosure of, such Confidential Information and not use such Confidential Information except
for the limited purposes set forth in this Agreement. No provision of this Agreement shall be construed to preclude disclosure of Confidential
Information (i) to actual or potential sources of financing; provided that such sources are bound to the terms of this <U>Section 5.2</U>
to the same extent as if they were parties hereto; (ii) in connection with disclosure obligations that arise in connection with an initial
public offering; or (iii) to the extent required to be disclosed by applicable statute, rule or regulation of any court or regulatory
authority with competent jurisdiction; provided that the disclosing Party shall be notified as soon as reasonably possible and the receiving
Party shall, if requested by the disclosing Party, use reasonable good faith efforts to assist in seeking a protective order (or equivalent)
with respect to such disclosure or otherwise take reasonable steps to avoid making such disclosure. For the avoidance of doubt, from
and after the Closing that portion of the Confidential Information included in the Purchased Assets shall be deemed to constitute Confidential
Information of Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Neither Party shall, directly or indirectly, issue any press release or other public statement relating to the terms of this Agreement
or the transactions contemplated hereby without the prior approval of the other Party (which shall not be unreasonably delayed, conditioned
or withheld), except (i) to the extent required by any Applicable Laws, (ii) as reasonably necessary to obtain any requisite consents
and approvals contemplated by this Agreement, or (iii) to the extent necessary for a Party to comply with its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Seller, hereby releases, on behalf of Seller and its Affiliates, Buyer and its officers, directors, employees and consultants from all
obligations they may have with respect to that portion of the Confidential Information included in the Purchased Assets under any confidentiality
agreement with or policy of any Seller covering such Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.3 <U>Further Assurances</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Prior to Closing, each Party shall use commercially reasonable efforts to take such action as is reasonably necessary or appropriate
in order to complete the transactions contemplated hereby on the terms and subject to the conditions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
For a period of twelve (12) months after the Closing, at the reasonable request of Buyer from time to time during normal business hours,
Seller shall (i) use commercially reasonable efforts to obtain and deliver such Third Party consents and (ii) execute, acknowledge and
deliver, or will cause to be done, executed, acknowledged and delivered, to Buyer such further acts, deeds, conveyances, transfers, assignments,
powers of attorney, assurances, certificates, consents and other instruments of sale, conveyance, assignment and transfer, and take such
other commercially reasonable action at the expense of Buyer, in each case, as may reasonably be requested by Buyer to carry out the
purposes of this Agreement or any other Purchase Agreement, or to more effectively convey, transfer to and vest in Buyer, and to put
Buyer in possession of, any of the Purchased Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.4 <U>Indemnity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Seller shall indemnify, defend and hold harmless Buyer and its Affiliates (the &ldquo;<B>Buyer Indemnified Parties</B>&rdquo;) from,
against, and in respect of, all losses, costs, charges, fines, fees, penalties, interest, awards, judgments, claims (including Third
Party claims), damages or expenses of whatever kind (including attorneys&rsquo; fees and expenses and the costs of enforcing any right
to indemnification hereunder) against or incurred by them (&ldquo;<B>Losses</B>&rdquo;) to the extent arising out of or relating to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any breach of any representation or warranty of Seller set forth in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any breach of any covenant, agreement or undertaking made by Seller in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any Excluded Asset or Excluded Obligation; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
other than any Excluded Obligation, any Liability (including any Liability related to Taxes) imposed upon Buyer or any of its Affiliates
by reason of its status as transferee of, or successor to, the Products or the Purchased Assets (including any Liability imposed upon
Buyer or any of its Affiliates as a result of the failure by Seller to comply with its obligations under any applicable bulk transfers
Laws or Tax clearance certificate requirements under applicable state Tax law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Buyer shall indemnify, defend and hold harmless Seller from, against and in respect of any and all Losses arising out of or relating
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any breach of any representation or warranty of the Buyer set forth in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any breach of any covenant, agreement or undertaking made by the Buyer in this Agreement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any Assumed Obligation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Notice of Claims</U>. If any of the Persons to be indemnified under this <U>Section 5.4</U> (the &ldquo;<B>Indemnified Party</B>&rdquo;)
has determined that any matters (other than a Third Party Claim) has given or could give rise to a right of indemnification under this
Agreement, the Indemnified Party shall so notify the Party from whom indemnification is sought (the &ldquo;<B>Indemnifying Party</B>&rdquo;)
promptly, describing in reasonable detail, the basis for such claim. If any Indemnified Party receives written notice of the assertion
of any Action (in equity or at law) instituted by a Third Party (a &ldquo;<B>Third Party Claim</B>&rdquo;) with respect to which the
Indemnified Party intends to claim any Loss under this <U>Section 5.4</U>, the Indemnified Party shall promptly notify the Indemnifying
Party of such Action (the &ldquo;<B>Third Party Claim Notice</B>&rdquo;), describing in reasonable detail, the basis for such claim.
A failure by the Indemnified Party to give notice of any Action in a timely manner pursuant to this <U>Section 5.4(c)</U> shall not limit
the obligation of the Indemnifying Party under this <U>Section 5.4</U>, except (i) to the extent such Indemnifying Party is actually
prejudiced thereby or (b) as provided in <U>Section 6.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Third Party Claims</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Indemnifying Party under this <U>Section 5.4</U> shall have the right, but not the obligation, exercisable by written notice to the
Indemnified Party within ten (10) days of receipt of the Third Party Claim Notice, to assume the conduct and control, at the expense
of the Indemnifying Party and through counsel of its choosing that is reasonably acceptable to the Indemnified Party, of any Third Party
Claim; provided, that the Indemnified Party shall have the right to participate in, but not control, the defense of any such Third Party
Claim through counsel chosen by the Indemnified Party, whose fees and expenses shall be borne by the Indemnified Party. If the Indemnifying
Party fails to provide written notice within ten (10) days of receipt of a Third Party notice that it has elected to assume the defense
of such Third Party Claim, then the Indemnified Party shall be entitled to assume the defense of such Third Party Claim at the expense
of the Indemnifying Party; provided that the Indemnified Party may not compromise or settle any Third Party Claim except as provided
in <U>Section 5.4(d)(ii)</U>. For the avoidance of doubt, if the Indemnifying Party elects not to control or conduct the defense of a
Third Party Claim, the Indemnifying Party nevertheless shall have the right to participate in the defense of any Third Party Claim and,
at its own expense, to employ counsel of its own choosing for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Indemnifying Party may compromise or settle a Third Party Claim; provided, that the Indemnifying Party shall give the Indemnified
Party advance written notice of any proposed compromise or settlement and shall not, without the prior written consent of the Indemnified
Party (which consent shall not be unreasonably withheld, conditioned or delayed), consent to or enter into any compromise or settlement
that commits the Indemnified Party to take, or to forbear to take, any action or does not provide for a full and complete written release
by the applicable third party of the Indemnified Party. No Indemnified Party may compromise or settle any Third Party Claim for which
it is seeking indemnification hereunder without the consent of the Indemnifying Party (which consent shall not be unreasonably withheld,
conditioned or delayed). No Indemnifying Party may consent to the entry of any judgment that does not relate solely to monetary damages
arising from any such Third Party Claim without the prior written consent of the Indemnified Party (which consent shall not be unreasonably
withheld, conditioned or delayed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Parties shall cooperate in the defense of any Third Party Claim, with such cooperation to include (i) the retention and the provision
to the Indemnifying Party of records and information that are reasonably relevant to such Third Party Claim and (ii) reasonable access
to employees on a mutually convenient basis for providing additional information and explanation of any material provided hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Notwithstanding anything to the contrary herein, except for fraud and indemnification pursuant to <U>Section 5.4(a)(iii)</U>, the aggregate
liability for the Seller or an Indemnifying Party under this Agreement shall in no event exceed the Purchase Price paid to the Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.5 <U>Noncompetition</U>. During the period ending on the fifth (5<SUP>th</SUP>) anniversary of the Closing, neither Seller nor any
of its Affiliates shall, in any jurisdiction in the world, conduct, participate in, or directly fund, whether directly or indirectly
(with or via an Affiliate or a Third Party), the Commercialization or Development of any Polo-like Kinase (PLK) inhibitors, specifically
PLK1, or any associated PLK1 compound, PLK1 product or PLK1 clinical trial study in solid tumor or hematological malignancy indications,
or any other compound or product competitive or similar to the Compound or the Product (collectively, a &ldquo;<B>Competitive Business</B>&rdquo;),
provided, however, that nothing herein shall prohibit Seller or any of its Affiliates from acquiring any Competitive Business in connection
with the broader acquisition of any Person or assets so long as (i) the primary purpose of such acquisition is not to own any interest
in, manage or control any Competitive Business, (ii) any assets primarily relating to a Competitive Business do not constitute more than
thirty percent (30%) of the assets acquired in any such acquisition, and, (iii) such acquired Competitive Business or assets exclude
Commercialization or Development of PLK inhibitors for solid tumor or hematological malignancy indications..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.6 <U>Product Inquiries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
and after the Closing, Seller shall direct all Product-related inquiries to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.7 <U>Ownership Transfer</U>. Promptly following Closing, to the extent necessary to transfer ownership to Buyer of all Regulatory Filings
and Approvals filed with Governmental Authorities, the Parties shall execute and deliver to such Governmental Authorities such documents
as shall be required to accomplish such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.1 <U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement and the Exhibits, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with such
other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Law</B>&rdquo; means all federal, provincial, state, local and foreign law (including United States), (statutory, common or otherwise),
constitution, treaty, convention, ordinance, code, rule, regulation, order, injunction, judgment, decree, ruling or other similar requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business</B>&rdquo;
means the business of Developing and Manufacturing the Compound and Commercialization of a Product and includes any other actions taken
in furtherance thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Clinical
Trial</B>&rdquo; means any Phase 1 Clinical Trial, Phase 2 Clinical Trial, or Phase 3 Clinical Trial and/or variations or subsets of
such trials; &ldquo;<B>Phase 1 Clinical Trial</B>&rdquo; means a controlled human clinical trial that would satisfy the requirements
of 21 C.F.R. 312.21(a) or foreign equivalents thereof; &ldquo;<B>Phase 2 Clinical Trial</B>&rdquo; means a controlled human clinical
trial that would satisfy the requirements of 21 C.F.R. 312.21(b) or foreign equivalents thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Date</B>&rdquo; means the date on which the Closing occurs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CMC</B>&rdquo;
means the information related to chemistry, manufacture and controls submitted with the IND for the Compound pursuant to 21 C.F.R. 312.23(a)(i)(7).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialize</B>&rdquo;
means to market, promote, distribute, import, export, offer to sell or sell Products or conduct other Commercialization, and &ldquo;<B>Commercialization</B>&rdquo;
means commercialization activities relating to Products, including activities relating to marketing, promoting, distributing, importing,
exporting, offering for sale or selling Products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Combination
Product</B>&rdquo; means a Product that includes at least one additional active ingredient other than the Compound. Drug delivery vehicles,
adjuvants, and excipients will not be deemed to be &ldquo;active ingredients&rdquo;, except in the case where such delivery vehicle,
adjuvant, or excipient is recognized as an active ingredient in accordance with 21 C.F.R. &sect; 210.3(b)(7) (as amended), or any foreign
counterpart.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Compound</B>&rdquo;
means the Polo-Like Kinase (PLK) Inhibitor known as &ldquo;Plogosertib,&rdquo; as further described on <U>Exhibit C</U>, including all
salts, esters, hydrates, solvates, polymorphs, stereoisomers, crystalline forms, metabolites, prodrugs, derivatives, and formulations
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential
Information</B>&rdquo; means all information and data, regardless of form, including a formula, pattern, compilation, program, method,
technique, process, inventory, chemical, physical material, chemical structure or activity, design, prototype, drawings, samples, source
code, business plan, business opportunity, customer or personnel list, or financial statement proprietary to a Party or its Affiliate,
except any portion thereof which:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
is known to the receiving Party prior to receipt from the disclosing Party, as established by contemporaneously created written records;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
is disclosed to the receiving Party by a Third Party, as evidenced by the receiving Party&rsquo;s contemporaneously created written records,
who is under no obligation of confidentiality to the disclosing Party with respect to such information and who otherwise has a right
to make such disclosure;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
is or becomes published, as evidenced by a written version thereof, or generally known in the trade through no fault of the receiving
Party; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
is independently developed by the receiving Party, without resort to the disclosing Party&rsquo;s Confidential Information, by persons
having no access thereto, as evidenced by the receiving Party&rsquo;s contemporaneously created written records.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information and data included within the Purchased Assets that immediately prior to Closing constitutes Confidential Information of Seller
(without regard to clause (a) or (b) above) shall, from and after Closing, be deemed to constitute Confidential Information of Buyer,
except that Seller and its Affiliates shall continue to have the right to use such information and data for the purposes set out in <U>Section
5.1</U> or to otherwise use and disclose such Confidential Information as expressly permitted under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Contract</B>&rdquo;
means any written or oral legally binding contract, agreement, instrument, commitment, obligation, understanding, or undertaking of any
nature (including leases, licenses, mortgages, notes, guarantees, sublicenses, subcontracts, covenants not to compete, confidentiality
agreements, options and warranties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Control</B>&rdquo;
(including any variations such as &ldquo;<B>Controlled</B>&rdquo; and &ldquo;<B>Controlling</B>&rdquo;) means, with respect to any item
or Patent, Know-How, or other intellectual property right, the legal authority or right (whether by ownership or license, other than
by a license or sublicense granted pursuant to this Agreement) of a Party or its Affiliates to grant to the other Party the right to
use such item, or a license, sublicense or access as provided herein to such item, without violating the terms of any agreement or other
arrangement with any Third Party in existence as of the time such Party or its Affiliates would first be required hereunder to grant
the other Party such license, access, or other right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CRF</B>&rdquo;
means all case report forms relating to the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CRO</B>&rdquo;
means all contract research organizations or clinical research organizations that have performed or are performing clinical studies on
behalf of Seller or its Affiliates related to the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CSR</B>&rdquo;
means all clinical study reports relating to the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Develop</B>&rdquo;
or &ldquo;<B>Development</B>&rdquo; means drug development activities, including test method development and stability testing, assay
development and audit development, toxicology, formulation, quality assurance/quality control development, statistical analysis, clinical
studies, packaging development, regulatory affairs, and the preparation, filing and prosecution of INDs and MAAs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>DSMB</B>&rdquo;
means the Data Safety and Monitoring Board appointed for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>DSUR</B>&rdquo;
means all Development Safety Update Reports submitted to the FDA for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ECs</B>&rdquo;
means the established conditions for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FDA</B>&rdquo;
means the United States Food and Drug Administration or any successor entity thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Authority</B>&rdquo; means any nation or government, any provincial, state, regional, local or other political subdivision thereof, any
supranational organization of sovereign states, and any entity, department, commission, bureau, agency, authority, board, court, official
or officer, domestic or foreign, exercising executive, judicial, regulatory or administrative functions of or pertaining to government.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Health
Care Law</B>&rdquo; shall mean all applicable Laws relating to patient care and human health and safety, including any such applicable
Law pertaining to: (i) the research, development, testing, production, manufacturing, marketing, transfer, distribution, pricing and
sale of drugs and medical devices, including the United States Food, Drug and Cosmetics Act, as amended, and all related rules, regulations
and guidelines, the United States Public Health Service Act and all related rules, regulations and guidelines, and equivalent applicable
Laws of other applicable Governmental Authorities; and (ii) the privacy and security of patient-identifying health care information,
including the United States Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. 1320d et seq.) and all related rules,
regulations and guidelines thereof and equivalent applicable Laws of other applicable Governmental Authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>IB</B>&rdquo;
means the Investigator&rsquo;s Brochure for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ICF</B>&rdquo;
means all informed consent forms received by Seller or Third Parties for clinical studies for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>IMP</B>&rdquo;
means an investigational medicinal product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>IND</B>&rdquo;
means an Investigational New Drug Application in the United States for authorization to market any Product, as defined in the applicable
laws and regulations and filed with the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indebtedness</B>&rdquo;
with respect to any Person means, as of any time of determination, without duplication, the aggregate amount of: (a) all indebtedness
or other obligation for borrowed money, (b) all indebtedness evidenced by any note, bond, debenture, mortgage or other debt instrument
or debt security or similar instrument, (c) all obligations with respect to leases that would be required to be capitalized or otherwise
recorded as finance leases pursuant to GAAP, (d) amounts owing as deferred purchase price of property or services (other than trade payables
and any accrued capital expenditures in the ordinary course of business), including, for the avoidance of doubt, any earnouts, seller
notes, holdbacks or similar obligations related to past acquisitions, (e) obligations under any performance, surety or similar bond or
any letter of credit, but in each case only to the extent drawn or called (and not paid in full or otherwise discharged) and excluding
any obligations in respect of undrawn letters of credit, (f) all obligations arising from or under, or otherwise in respect of any unpaid
commissions; (g) all obligations secured by (or for which the holder of such indebtedness has an existing right, contingent or otherwise,
to be secured by) any Lien on property associated with the Products; (h) all obligations under conditional sale or other title retention
agreements relating to property or assets associated with the Products; (i) all outstanding obligations to current and former equityholders
in their capacity as such, including any unpaid dividends or distributions or any unpaid management or advisory fees under any management
services or similar agreements with any Affiliate or holder of equity interests of Seller that are associated with the Products; and
(j) all obligations with respect to government assistance programs that are subject to clawbacks or other mandatory repayments (whether
or not such terms are triggered prior to the date of determination); (k) with respect to any indebtedness of a type described in <U>clauses
(a)</U> through <U>(j)</U> above of any Person that is guaranteed by Seller or that is secured by any of the Purchased Assets; (l) for
<U>clauses (a)</U> through <U>(k)</U> above, all accrued and unpaid interest thereon, if any, and any fees, costs, expenses or other
payment obligations associated with any required repayment of such indebtedness on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Inventory</B>&rdquo;
means all raw materials, finished Products and intermediates, and works in process thereof related to the Business (including the drug
substances, Compound or any other active pharmaceutical ingredient for Products or any reagents, cell lines, biological or chemical materials,
samples or other materials used exclusively or primarily in the research or development of Products), wherever located, whether in the
possession of Seller or Third Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>IRB</B>&rdquo;
means all Institutional Review Boards reviewing any clinical investigation relating to the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Know-How</B>&rdquo;
means any and all tangible, proprietary, confidential, research, technical and scientific information existing as of the effective date
of this Agreement that is not in the public domain, including information relating to materials, discoveries, unpatented inventions,
improvements, practices, methods, protocols, manufacturing techniques, operating manuals, databases, formulas, knowledge, trade secrets,
technologies, computer software programs and applications (including data files, source code, object code and software-related specifications
and documentation), processes, assays, sources, skills, experience, techniques, data and the results of experimentation and testing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Knowledge</B>&rdquo;
means, with respect to Seller, the actual knowledge, after reasonable inquiry of current employees of Seller responsible for the relevant
matter, of Datuk Dr. Doris Wong and Shabir Hussain, and with respect to Buyer, the actual knowledge after reasonable inquiry of the chief
executive officer of Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Liability</B>&rdquo;
means all debts, liabilities and obligations (including with respect to Taxes), whether accrued or fixed, absolute or contingent, matured
or unmatured, determined, determinable or indeterminable, asserted or unasserted, known or unknown, including those arising under any
Applicable Laws or Proceeding and those arising under any Contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Law</B>&rdquo;
means any federal, state, provincial, local, international or multinational law, statute, standard, ordinance, code, rule, regulation,
resolution or promulgation, or any order, writ, judgment, injunction, decree, stipulation, ruling, determination or award entered by
or with any Governmental Authority, or any license, franchise, permit or similar right granted under any of the foregoing, or any similar
provision having the force or effect of law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>MAA</B>&rdquo;
means an application for the authorization to market any Product in any country or group of countries outside the United States, as defined
in the applicable laws and regulations and filed with the Governmental Authority of a given country or group of countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Manufacture</B>&rdquo;
means activities related to the manufacture, formulation and packaging of the Compound or any Product, including related quality control
and quality assurance activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Adverse Effect</B>&rdquo; means any change, circumstance or effect that, individually or in the aggregate, would or would reasonably
be expected to (i) have a materially adverse effect on the Purchased Assets taken as a whole, including the value thereof, or on Buyer&rsquo;s
ability to receive and develop the Purchased Assets free and clear of any Liens (other than Permitted Liens) pursuant hereto or (ii)
prevent or materially delay consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Patents</B>&rdquo;
means national and multinational statutory invention registrations, patents, patent applications (including provisional applications)
or utility models, as well as all renewals, reissues, divisions, substitutions, converted applications, continuations, continuations-in-part,
continued prosecution applications, extensions, confirmations, revalidations, restorations, substitutions, reexaminations and supplementary
protection certificates and all foreign counterparts thereof, registered or applied for in the United States and all other nations throughout
the world, and all rights of priority in any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permits</B>&rdquo;
means all permits, licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained,
or required to be obtained, from Governmental Authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Plogosertib</B>&rdquo;
means all of Seller&rsquo;s right, title and interest in and to the Compound and Seller&rsquo;s Plogosertib PLK inhibitor program, including
all related assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Proceeding</B>&rdquo;
means any action, suit, litigation, mediation, arbitration, proceeding (including any civil, criminal, administrative, investigative
or appellate proceeding and any informal proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation
commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Authority or any arbitrator or arbitration
panel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Product</B>&rdquo;
means any pharmaceutical product containing the Compound (alone or with other active ingredients), in all forms, presentations, formulations
and dosage forms. For clarification, Product will include any Combination Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PSUR</B>&rdquo;
means all postmarketing safety reporting information submitted to the FDA for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchased
IP</B>&rdquo; means any and all intellectual property rights and other similar proprietary rights in any jurisdiction, whether registered
or unregistered, whether owned or held for use under license, including all rights and interests pertaining to or deriving from (i) all
Patents and Know-How Controlled by Seller or its Affiliate that are exclusively or primarily related to the Compound or any Product,
including, without limitation, the Patents and the intellectual property rights and other similar proprietary rights set forth on <U>Schedule
1.1(a)</U>, (ii) industrial designs (whether or not registered), (iii) any other proprietary or intellectual property rights now known
or hereafter recognized in any jurisdiction, (iv) all rights to recover and retain damages and costs and attorneys&rsquo; fees for past,
present and future infringement or misappropriation of any of the foregoing, (v) all rights in and to the master cell bank(s) and stability
materials relating exclusively or primarily to the Compound or Products, (vi) trademarks, service marks, trade names, domain names, copyrights
related to the Products, and (vii) all safety data, preclinical data, correlative data, clinical data, trial master files, electronic
databases generated during the ongoing or completed clinical trials of Plogosertib, in each of the cases (i) to (vii), whether provided
by treaties, conventions and common law, and including any registrations of, applications to register, and renewals and extensions of,
any of the foregoing with or by any Governmental Authority in any jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Regulatory
Filings and Approvals</B>&rdquo; means, with respect to any pharmaceutical product in any jurisdiction, any and all regulatory applications,
filings, approvals, reports, scientific data (including pre-clinical and clinical data, laboratory records, data and information related
to any Product), notifications, registrations and associated correspondence required to develop, manufacture, market, sell, and import
such product in, or into, any jurisdiction, and all approvals from any regulatory authority necessary for the sale of such product in
a given jurisdiction in accordance with all Applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Retained
Tax Liabilities</B>&rdquo; means (i) any Taxes of Seller, (ii) any Taxes related to the Purchased Assets that were incurred in or are
attributable to any taxable period (or portion thereof) ending on or before the Closing Date, (iii) any Taxes of another person for which
Seller is liable, including, but not limited to Taxes for which Seller is liable by reason of Treasury Regulations Section 1.1502-6 (or
any comparable or similar provision of federal, state, local or foreign Law), being a transferee or successor, any contractual obligation
or otherwise, and (iv) any income, transfer, sales, use or other Taxes arising in connection with the consummation of the transactions
contemplated by this Agreement (including any income Taxes arising as a result of the transfer by Seller to Buyer of the Purchased Assets),
other than Buyer&rsquo;s share of transfer and other Taxes pursuant to Section 5.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SAP</B>&rdquo;
means all statistical analysis plans for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller
Employees Liabilities</B>&rdquo; means any (a) employment claim and any other Liability for accrued wages, salaries, commissions, bonuses,
workers&rsquo; compensation, medical or disability benefits, vacation, sick or other paid-time off or comprehensive leave benefits of
or relating to the employment or services, or termination of any current or former Seller employees or consultants or independent contractors
of Seller or any of its Affiliates, whether pursuant to any contract or under any Applicable Law or otherwise; (b) Liabilities under
any of Seller&rsquo;s employee benefit arrangements or any contracts or other compensatory arrangements with Seller&rsquo;s employees
or with independent contractors or consultants of Seller or any its Affiliates (including, for the avoidance of doubt, any change in
control, severance or similar payments under any contracts with or Seller&rsquo;s employee benefit arrangements covering such employees);
(c) any other Liabilities owing to current or former Seller employees, consultants or independent contractors of Seller or any of its
Affiliates pursuant to their employment or services with or termination from Seller or any its Affiliates, as the case may be, or (d)
any penalties, fines or other expenses resulting from compliance issues with any Laws regulating employment or benefits plus any payroll
Taxes of Seller or its Affiliates attributable to such Liabilities under clauses (a)-(d), together with any interest or penalties thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SOP</B>&rdquo;
means all standard operating procedures for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SOW</B>&rdquo;
means all statements of work relating to the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Tax</B>&rdquo;
means any federal, state, local or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation,
premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding, social security, unemployment,
disability, real property, personal property, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated,
or other tax, including any interest, penalty or addition thereto, imposed by any Governmental Authority responsible for the imposition
of any such tax (domestic or foreign).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
Party</B>&rdquo; means any Person other than Buyer, Seller or their respective Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>TLF</B>&rdquo;
means all tables, listings, and figures for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>TMF</B>&rdquo;
means all trial master files for the Compound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.2 <U>Survival of Representations and Warranties and Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations and warranties of the Parties contained in this Agreement shall survive the Closing until the date that is twelve (12)
months after the Closing Date, provided, that (i) the representations and warranties set forth in <U>Sections 2.1</U>, <U>2.2(b)</U>,
<U>2.3</U>, <U>4.1</U> and <U>4.2</U> shall survive the Closing until the fifth year anniversary of the Closing, and (ii) the representations
and warranties in <U>Section 2.9</U> shall survive the Closing until the expiration of the applicable statute of limitations period plus
90 days. The covenants and agreements of the Parties contained in this Agreement shall survive the Closing in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.3 <U>Notices</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests, demands and other communications which are required or may be given under this Agreement shall be in writing and shall
be deemed to have been duly given when received if personally delivered; upon receipt if transmitted by email; the day after it is sent,
if sent for next day delivery to a U.S. address by recognized overnight delivery service (<I>e.g.</I>, Federal Express); and upon receipt,
if sent by certified or registered mail, return receipt requested, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
to Buyer:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tethra
Biosciences Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39
Delwick Lane</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
Hills, New Jersey 07078</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention
: Dhaval Parikh</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy (which shall not constitute notice) to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
Northern Ave</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston,
MA 02210</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MKatz@goodwinlaw.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mayan Katz</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
to Seller:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bio
Green Med Solution, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
10, Tower 11, Avenue 5, No. 8</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jalan
Kerinichi,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuala
Lumpur, Malaysia 59200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Datuk Dr. Doris Wong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy (which shall not constitute notice) to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rimon,
P.C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">423
Washington Street, Suite 600</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Francisco, California 94111 U.S.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mark Lee; Debbie Klis</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other place and with such other copies as either party may designate as to itself by written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.4 <U>Governing Law; Jurisdiction</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement will be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law
principles thereof. Each of the Parties irrevocably agrees that any Proceeding arising out of or relating to this Agreement brought by
any other party or its successors or assigns shall be brought and determined in the Court of Chancery of the State of Delaware, New Castle
County, or, if that court does not have jurisdiction, a federal court sitting in Wilmington, Delaware, and each of the Parties hereby
irrevocably submits to the exclusive jurisdiction of the aforesaid courts for itself and with respect to its property, generally and
unconditionally, with regard to any such Proceeding arising out of or relating to this Agreement and the transactions contemplated hereby.
Each of the Parties agrees not to commence any Action relating thereto except in the courts described above, other than Actions in any
court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court. Each of the Parties further agrees
that notice as provided herein shall constitute sufficient service of process and the Parties further waive any argument that such service
is insufficient. Each of the Parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as
a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts described herein for any reason, (b) that it
or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through
service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) or (c)
that (i) the Action in any such court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this Agreement,
or the subject matter hereof, may not be enforced in or by such courts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.5 <U>Waiver of Jury Trial</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT,
THE PURCHASE AGREEMENTS OR ANY OTHER AGREEMENTS CONTEMPLATED HEREBY OR THE CONTEMPLATED TRANSACTIONS AND FOR ANY COUNTERCLAIM THEREIN.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.6 <U>Payments; Expenses</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, no payments shall become due and payable and neither Party will be obligated to reimburse the other Party for
any costs incurred by the other Party under or in connection with this Agreement unless and until the Closing has occurred. Except as
otherwise specified herein, all costs and expenses, including fees and disbursements of counsel, financial advisors and accountants,
incurred in connection with this Agreement and the transactions contemplated hereby will be paid by the Party incurring such costs and
expenses, whether or not the Closing will have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.7 <U>Counterparts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute
one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.8 <U>Entire Agreement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement, including the Schedules and Exhibits hereto and the documents referred to herein, embodies the entire agreement and understanding
of the Parties hereto in respect of the subject matter contained herein. This Agreement supersedes all prior agreements and understandings
(including any confidentiality agreements) between the Parties with respect to such subject matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.9 <U>Amendment and Modification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be amended or modified only by written agreement of the Parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.10 <U>Binding Effect; Benefits</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall inure to the benefit of and be binding upon the Parties hereto and their respective successors and assigns; nothing in
this Agreement, express or implied, is intended to confer on any Person other than the Parties hereto and their respective successors
and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.11 <U>Assignability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall not be assignable by any Party hereto without the prior written consent of the other Party except that (i) either Party
may assign its rights under this Agreement to any of such Party&rsquo;s Affiliates without the prior written consent of the other Party
and (ii) Buyer may assign its rights under this Agreement to any Person acquiring all of the Products or Purchased Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.12 <U>Interpretation Provisions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The words &ldquo;hereof,&rdquo; &ldquo;herein&rdquo; and &ldquo;hereunder&rdquo; and words of similar import when used in this Agreement
refer to this Agreement as a whole and not to any particular provision of this Agreement, and Article, Section, Schedule and Exhibit
references are to this</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement
unless otherwise specified. The meaning of defined terms shall be equally applicable to the singular and plural forms of the defined
terms. The term &ldquo;or&rdquo; is inclusive and not exclusive, unless its use is preceded by the word &ldquo;either&rdquo; or other
words of similar import. The terms &ldquo;include&rdquo; and &ldquo;including&rdquo; are not limiting and mean &ldquo;including without
limitation.&rdquo; Use of a particular gender is for convenience only and is not intended to be a part of or to affect or restrict the
meaning or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
References to agreements and other documents shall be deemed to include all subsequent amendments and other modifications thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
References to statutes shall include all regulations promulgated thereunder and references to statutes or regulations shall be construed
as including all statutory and regulatory provisions consolidating, amending or replacing the statute or regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The captions and headings of this Agreement are for convenience of reference only and shall not affect the construction of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent, and no rule
of strict construction shall be applied against any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Schedules and Exhibits to this Agreement are a material part hereof and shall be treated as if fully incorporated into the body of
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.13 <U>Severability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid
under Applicable Law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable
in any respect under any Applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect
the validity, legality or enforceability of any other provision or portion of any provision in such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.14 <U>Specific Performance; Equitable Remedies</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties agree that irreparable damage would occur in the event any provision hereof were not performed in accordance with the terms hereof
and that the Parties will be entitled to specific performance of the terms hereof, in addition to any other remedy at law or in equity
without the necessity of demonstrating the inadequacy of monetary damages and without the posting of a bond.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties agree that irreparable harm would occur in the event that any of the agreements and provisions of this Agreement were not performed
fully by the Parties in accordance with their specific terms or conditions or were otherwise breached, and that money damages alone are
an inadequate remedy for breach of this Agreement because of the difficulty of ascertaining and quantifying the amount of damage that
will be suffered by the Parties in the event that this Agreement is not performed in accordance with its terms or conditions or is otherwise
breached. It is accordingly hereby agreed that a Party shall be entitled to an injunction or injunctions to restrain, enjoin and prevent
breaches of this Agreement by the other Party and to enforce specifically the terms and provisions hereof in the courts specified in
Section 6.4, such remedy being in addition to and not in lieu of, any other rights and remedies to which such other Party is entitled
to at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.15 <U>Obligations of Party&rsquo;s Affiliates</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall cause its controlled Affiliates that are entities to perform any obligations of such Party and its Affiliates that are entities
in connection with the Purchased Assets and the consummation of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have duly executed this Agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>BIO GREEN MED SOLUTION, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk Dr. Doris Wong Sing Ee</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUYER:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TETHRA BIOSCIENCES INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dhaval Parikh</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Asset Purchase Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BILL
OF SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BILL
OF SALE AND ASSIGNMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
BILL OF SALE AND ASSIGNMENT (this &ldquo;<B>Bill of Sale</B>&rdquo;), dated October 6, 2025, is by and between Tethra Biosciences Inc.,
a corporation organized under the laws of the State of Delaware (&ldquo;<B>Buyer</B>&rdquo;), and Bio Green Med Solution, Inc., a company organized
under the laws of the State of Delaware (&ldquo;<B>Seller</B>&rdquo;). Capitalized terms used but not defined herein will have the meanings
given to them in the Asset Purchase Agreement, dated October 6, 2025 (the &ldquo;<B>Agreement</B>&rdquo;), by and between Buyer and Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1.</U> Buyer and Seller are parties to the Agreement, providing for, among other things, the transfer of the Purchased Assets by Seller
to Buyer. Notwithstanding the foregoing, the Purchased Assets transferred, assigned, conveyed and delivered under this Bill of Sale shall
not include the Excluded Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2.</U> In consideration of the mutual obligations, releases and promises set forth in the Agreement, Seller by this Bill of Sale does
hereby convey, grant, bargain, transfer, assign, release and deliver to Buyer, and its successors and assigns, all the right, title and
interest of Seller in and to the Purchased Assets free and clear of all Liens except Permitted Liens, as those terms are defined in the
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3.</U> Seller hereby appoints Buyer, and its successors and assigns, as Seller&rsquo;s true and lawful attorney, with full power or substitution,
in Seller&rsquo;s name but on behalf and for the benefit of Buyer, and its successors and assigns, to demand and receive any and all
of the Purchased Assets, to give receipts and releases for and in respect of the same and any part thereof, and from time to time to
institute and prosecute in Seller&rsquo;s name or otherwise, for the benefit of Buyer, and its successors and assigns, any and all proceedings
at law, in equity or otherwise, which Buyer, and its successors or assigns, may deem proper for the collection or reduction to possession
of any of the Purchased Assets or for the collection and enforcement of any claim or right of any kind hereby conveyed, transferred and
assigned, or intended so to be, and to do all acts relating to the Purchased Assets which Buyer, and its successors or assigns, will
deem desirable. This power of attorney is coupled with an interest and is irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4.</U> Nothing in this Bill of Sale, express or implied, is intended or shall be construed to expand or defeat, impair or limit in any
way the rights, obligations, claims or remedies of the parties as set forth in the Agreement. In the event of any conflict or inconsistency
between the terms of the Agreement and the terms hereof, the terms of the Agreement shall govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5.</U> This Bill of Sale is executed by, and will be binding upon, Seller and Buyer and their respective successors and assigns, effective
immediately on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6.</U> This Bill of Sale and Assignment shall be governed by and construed in accordance with the Laws of the State of Delaware (excluding
any principles of conflicts of laws that would cause the application of the laws of any other jurisdiction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7.</U> This Bill of Sale and Assignment may be executed by facsimile or .PDF signature. This Bill of Sale may be executed in any number
of counterparts, all of which taken together shall constitute one and the same agreement and any of the parties hereto may execute this
Bill of Sale by signing any such counterpart. Any individual signing this Bill of Sale represents and warrants that he or she has full
authority to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of page intentionally left blank]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, this Bill of Sale and Assignment has been duly executed and delivered by the parties hereto as of the date and year
first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIO
    GREEN MED SOLUTION, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TETHRA
    BIOSCIENCES INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PATENT
ASSIGNMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PATENT
ASSIGNMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Patent Assignment (this &ldquo;<U>Assignment</U>&rdquo;) is executed and delivered as of October 6, 2025 by and between Bio Green Med
Solution, Inc., a Delaware corporation with its principal place of business at Level 10, Tower 11, Avenue 5, No. 8, Jalan Kerinichi,
Kuala Lumpur, Malaysia (&ldquo;<U>Assignor</U>&rdquo;) and Tethra Biosciences Inc., a Delaware corporation with its principal place of
business at 39 Delwick Lane, Short Hills, New Jersey 07078 (&ldquo;<U>Assignee</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignor
owns the entire right, title, and interest in and to each patent and patent application listed on <U>Schedule 1</U> hereto, and the inventions
described in and underlying such patents and patent applications (collectively, the &ldquo;<U>Patents</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignor
and Assignee are parties to that certain Asset Purchase Agreement dated October 6, 2025 (&ldquo;<U>Agreement</U>&rdquo;), pursuant to
which Assignor has agreed, inter alia, to transfer certain assets; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Agreement and subject to the terms of this Assignment, the Assignor wishes to assign to the Assignee all right, title, interest
in and to its rights in the Patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW
IT IS HEREBY AGREED AS FOLLOWS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. CONSIDERATION</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
good and valuable consideration given by or on behalf of the Assignee is the amount provided under the Agreement, the receipt and adequacy
of which are hereby acknowledged by Assignor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
ASSIGNMENT</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Assignor hereby assigns, sells, conveys, transfers, and delivers to the Assignee, and the Assignee hereby purchases, accepts and acquires,
all of the entire right, title and interest in and to the Patents, together with all rights, privileges, and advantages thereto, including,
without limitation, the right to take, defend, or appeal proceedings and recover (and retain) damages, and obtain all other remedies
in respect to past infringements thereof, and the right to file patent applications under the laws of the United States and any other
country that claim priority from any patent application therein, wherever such right may be legally exercised, including the right to
claim the benefits of the International Convention for such applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignor
hereby authorizes and requests the United States Commissioner of Patents, and the Patent Office officials in foreign countries as are
duly authorized by the respective foreign patent laws to issue patents, to issue any and all patents directed to the Patents to the Assignee
as the owner thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, the term &ldquo;<U>Patents</U>&rdquo; shall include all continuations, continuations-in-part, and divisionals
of any United States patent application(s) or international patent application(s) designating the United States, any national stages
of any international application(s), and any other patent application(s) claiming priority to any patent listed in Schedule 1, including
further continuations, continuations-in-part, and divisionals such as, but not limited to, continuations of continuations and continuations
of divisionals; all patents, utility models, or other grants that issue from any of the applications referred to herein and all rights
and remedies associated therewith including the right to recover past damages and to recover under 35 U.S.C. &sect; 154 (d) or any other
law permitting remedies for infringement prior to issuance of the patent; all registrations and confirmations of, and importation certificates
based upon, one or more of said patents, utility models, or other grants, and applications for such registrations, confirmations and
importation certificates; and all reissues, renewals and extensions of said patents, utility models, registrations, confirmations and
importation certificates, reexamination certificates issued for said patents and supplementary protection certificates based upon said
patents and applications for such reissues, renewals, extensions, reexamination certificates and supplementary protection certificates,
the same to be held and enjoyed by said Assignee to the full ends of the terms for which said patents, utility models, registrations,
confirmations, importation certificates, reexamination certificates, supplementary protection certificates, reissues, renewals and extensions
may be granted, as fully and entirely as the same would have been held and enjoyed by me/us if this sale, assignment and transfer had
not been made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. FURTHER</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSURANCES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignor
hereby agrees to execute all documents, assist in all proceedings and take any reasonable further steps that are reasonably necessary
(at the sole cost and expense of Assignee) to effectuate the transfer of the Patents to Assignee, or the perfection, registration, or
recordation of the rights of Assignee thereto, as may be reasonably appropriate. If Assignor does not, within thirty (30) days of presentment,
return the requested executed documents, then Assignee is hereby granted a limited power of attorney to execute all such documents on
behalf of Assignor in accordance with 37 C.F.R. &sect; 3.73. This power of attorney is coupled with an interest and is irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. MISCELLANEOUS</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROVISIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
any provision of this Assignment be deemed invalid or unenforceable by reason of any law, statute, regulation or judgment, existing now
or in the future in any jurisdiction, such provision shall be modified in such jurisdiction so as to nearly approximate the intent of
the Parties. If this cannot be done, such invalid or unenforceable provision shall be divisible and be deleted in any such jurisdiction,
and all other provisions shall remain in full force and effect. The modification or deletion of any provision in one jurisdiction shall
have no effect on this Assignment in any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Assignment shall be governed by the laws of the State of Delaware, without regard to the conflict of law principles thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Assignment may be executed in two counterparts, and each such counterpart hereof shall be deemed to be an original instrument, but both
such counterparts together shall constitute but one agreement. Delivery of an executed counterpart of a signature page of this Assignment
by facsimile or other electronic transmission shall be effective as delivery of a manually executed original counterpart of this Assignment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Assignor and Assignee have caused this Patent Assignment to be duly signed on their behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignor:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIO
    GREEN MED SOLUTION, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Assignor and Assignee have caused this Patent Assignment to be duly signed on their behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignee:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TETHRA
    BIOSCIENCES INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: black 0.25pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Schedule
1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[****]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPOUND</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[****]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
D</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION
FOR THE COMPOUND</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[****]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>form8-k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form8-k_001.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  _ ,@# 2(  A$! Q$!_\0
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M?Q"US*LNCWOG>8L*J$/.?E/Q^9<,<9X# 3Q.:Y;G$,I3PV)G+$5*\<%>7/\
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MT*$N,$LC?,=S9VA V0 S' 4Y7&#@@@@X/%?S._&3_@DC^V+^R3\;?'O[3/\
MP1T^-OAWX91_$:[N=9\>_LI_$1H#\.M:U6Y6XO)[;P[>>(XM:\.G0_MT]P-
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M_2;_ ()_?LLZE^SO\*M3U;X@R'5OCM\8=<;XD_&77KF5;N\7Q#K0-VGAO[:
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=B2ZNU]WN]6]7U&DHZ+JVWHEJW=NT8P7X?-[G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bgms-20251006.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOCWbP9z5Z8uekhvWBxbbmavy4sLRGyMSv1a9ZmcYME -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:BGMS="http://bgmsglobal.com/20251006" elementFormDefault="qualified" targetNamespace="http://bgmsglobal.com/20251006">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bgmsglobal.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="bgms-20251006_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bgms-20251006_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bgms-20251006_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="BGMS_CommonStockParValue0.001PerShareMember" name="CommonStockParValue0.001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BGMS_PreferredStock0.001ParValueMember" name="PreferredStock0.001ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bgms-20251006_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="bgms-20251006.xsd#Cover" roleURI="http://bgmsglobal.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bgmsglobal.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bgms-20251006.xsd#BGMS_CommonStockParValue0.001PerShareMember" xlink:label="loc_BGMSCommonStockParValue0.001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BGMSCommonStockParValue0.001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bgms-20251006.xsd#BGMS_PreferredStock0.001ParValueMember" xlink:label="loc_BGMSPreferredStock0.001ParValueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BGMSPreferredStock0.001ParValueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bgms-20251006_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bgms-20251006.xsd#BGMS_CommonStockParValue0.001PerShareMember" xlink:label="BGMS_CommonStockParValue0.001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BGMS_CommonStockParValue0.001PerShareMember" xlink:to="BGMS_CommonStockParValue0.001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BGMS_CommonStockParValue0.001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="bgms-20251006.xsd#BGMS_PreferredStock0.001ParValueMember" xlink:label="BGMS_PreferredStock0.001ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BGMS_PreferredStock0.001ParValueMember" xlink:to="BGMS_PreferredStock0.001ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BGMS_PreferredStock0.001ParValueMember_lbl" xml:lang="en-US">Preferred Stock, $0.001 par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bgms-20251006_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="bgms-20251006.xsd#Cover" roleURI="http://bgmsglobal.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bgmsglobal.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bgms-20251006.xsd#BGMS_CommonStockParValue0.001PerShareMember" xlink:label="loc_BGMSCommonStockParValue0.001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BGMSCommonStockParValue0.001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bgms-20251006.xsd#BGMS_PreferredStock0.001ParValueMember" xlink:label="loc_BGMSPreferredStock0.001ParValueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BGMSPreferredStock0.001ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  06,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-50626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bio
Green Med Solution, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001130166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1707622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Level
10, Tower 11,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Avenue 5, No. 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Jalan
Kerinchi<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kuala Lumpur<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">MY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">59200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">517-7330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BGMS_CommonStockParValue0.001PerShareMember', window );">Common Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BGMS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BGMS_PreferredStock0.001ParValueMember', window );">Preferred Stock, $0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BGMSP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BGMS_CommonStockParValue0.001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BGMS_CommonStockParValue0.001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BGMS_PreferredStock0.001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BGMS_PreferredStock0.001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bgmsglobal.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bgms-20251006.xsd</File>
    <File>bgms-20251006_def.xml</File>
    <File>bgms-20251006_lab.xml</File>
    <File>bgms-20251006_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form8-k_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "BGMS",
   "nsuri": "http://bgmsglobal.com/20251006",
   "dts": {
    "schema": {
     "local": [
      "bgms-20251006.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bgms-20251006_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bgms-20251006_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bgms-20251006_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://bgmsglobal.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "auth_ref": []
    },
    "BGMS_CommonStockParValue0.001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bgmsglobal.com/20251006",
     "localname": "CommonStockParValue0.001PerShareMember",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "BGMS_PreferredStock0.001ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bgmsglobal.com/20251006",
     "localname": "PreferredStock0.001ParValueMember",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, $0.001 par value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bgmsglobal.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-25-017223-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-017223-xbrl.zip
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MMXRS"GHUJT. _V]"W: \>5S^ U!+ P04    "  /2$=;4&HOR/8(  !I:
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M%1TV9*/%!@F#FCN*-)\[MF6MOGK9IKYZ6:.O=A1IIJ3BA?KZNKN94[)$\([
MD@2M4!_B#1EAJ]-;&!'OUS(O9!/KB-6U_F"WP IMM/@P8U!V5UMAPX H',0$
MKPE#S-?!W+Y2P!V"JE3--J,.>= 7I\])_\24_L[X$YMA)#G#01Q8E#VM )(T
MVI%JYJ =3I^<_N T9 J):,FM *X-*[0%\ML8@[([?4B:+"O?CUSQFSK+U+>G
M:($))<1!+YP^/)TPA07R%7G$GY%""=\R+^PI6N!%"7'0"Z<+CZ,+=:SKL^3E
M:P=RP!8H7^0+"NYTO?%LC2B]#*6N@"SM?W+ %@A>Y L*[G1%\=4:BZ7N!K\(
M_J16R4;>,N&M"5I@ ,P;-,+IRN&K[?.+!>)=C:4N%-!ML,!.&M+_S/&VV0O?
M-TM-XCD!"Y  '(#QC?:@@C;H@J,P^4:ML,C.RB)JIC)E"T&J4C7:D5KD05^<
MALG9USR4#LL97*.U!^B":CN-@J?AG!+_FG)4.N_/P%J@]2%;4&JGD>\E8@\B
MW"A_-Q7<Q]@\&)+[:[)&\%4K@Q;84[\>H'%NM^(^OTHU>G6JO E5]+]3--O2
M&Q<EZ5I@4R5]T!W'KZ*2SUOV<'"YNS6O6S6+-^[P5EWJ@A[*)U>5R1OMU7&U
M "W+A-Z?>@<5U,4_Z'/)<?/+_+<7?>3_4$L#!!0    (  ](1UL4\J"AX@L
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MA #2O9-^6C5'HXO5K?UHJ9UL<4>7R85IZ-Y_*P4H#@U4.[X)!>91$Z]7O8I
MT^2].5H<L;_L?UE@]OP#4$L#!!0    (  ](1UN!,:M^^XD  %_=!  )
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M>%(99#G(!OP)0XW2(,J2X#:OTR1(]4>5+H(XJDL5Q/ELKBI=Z1L%@REF@9[
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M&J^6#30",0H$GX$KH3C#Y8,&T1"-TQJ+;OD[3BJ+E*2Z1-&%/8,GA$"*Z,B
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MH(7@-6 @768QK3W;LO#OJ HB3 *)LP66#IC<8!C'A3)Z3/([X*& 9HDP>E#
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MH@E@'?$FUKV&7O,J>?#))3['5M3Q6PO[;<WPF04P& L;%P>C$Z[C]8+"1W0
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M$>EF1+?GY_TSRV]3E5RK1E#5XI:LH04V1$=(-F/6+UNL'35"QY6TU[XK$&O
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M*5K=@E/&WI%P5)5EK>3?49;5FA@Q\+ZL7EV'20%2+#-$M5M)RMF'33K@*'5
M9L-P@8_$5PI;<&KBQD#K K^201)4H\A+DQU>PM: T,.!M60ZT9'(F2[+T/+G
M=C6LA52AP9S.P3C0/-H8QYD:0BX8(YR(<%Y[% GVB/+ZEL!G([+,NP(HC2'8
M1754"7-VEY"JH53"F5C"L\H)2I##P,B,SZRJ:%"N8+R.9S?TIS84])-= ^.D
M>1+9ZYH-&/Z.0EUS5_3-TP9L]>/F*_(9+2?B$/(%[7?"+:1(4,A_4)0N+_SM
M?ZZ*$A$,MU,!EM-E>ES[,327/4?[6# UYLCJV+%@6)D"56<3@N5,AZ?4M389
MB='RQ;:XR*2H!9/,UCPKFMP[9UM&*HDPFV"FM-:,ERQU&:XX0TU=1F"WACTJ
M@##C2=#=N2Z5'G'G4"Q4D+G_?+L6YLG,2)S/9G5F7'Y>MK9+Y5D)SL:PDF";
M<I#FRPL7^*U+U=L,FS+\G<GG]C$8I+S_2%I,F E.\9DNJ2YE7FAF=VQXOH(\
M25A^W4W@6"2(9E:E"W,W9OQIW(\.AHX;TN?$Q8A&,F]O-A^28$<<H%UZ9)VI
M3W,Z\B7 M[+O=,YUE*WW8?<?)^+9-+_MC=VOAV#9[Q$L#X]@^:%'L/0(EHU5
M"P]WGEW?XSQCY\>5@GGTX,O,F9*B,'Y;=UC%5959KVTXZ+B7%Y^AT#6&R*UC
MQ@XCVTE-/L^V^X0F72U1S5;SLZ6S;3B@Z#D^X]I0>WHFL9R=$G-BO]G53]P1
MZB$3FJ ?C,C(D4_4JX.3ZEAXVI&Z46D^MT6U[UP6K'O0JS)=UOB@]K$=YD<S
M%;9\%;NT?BA\.%B*A4_:[)Q]5=O:=O/4<>SB%IO414:U+QW]@QW_4>KUZ_!Y
M& TP2 2YR3G[&2S(< #>7ZR*S 1%FQ)[5WZV4*FZD< ]182BB6*UHK D+XH7
M+IE*+J4__@M+@PGG"A5S,T7)R%2$>VZR_9$C,E(V:.?=R,1Z,<;F9RSN3 $9
MM%93L0X'GF;EY*XWX9B]\/HU>XEXZLN^JK=*O]W6#WOY 6$OIS:,V&-=UHUU
M.;:%X@W>-0]5^0-<9T!OA%.4@OZ00_!D4L@'9:UA2].9;W+S6/ QHTV>Z()K
M"C$PA3'<!652Y[G*HI#.2^F.@L7F8^TBY_!A*^:,@:W2AJ)7EBNR/=8H4[P[
M3MY0.WZ7[T[CC,N65$*\!DQH81/HD@F5B]$<:]6^1X3_7-;ZI@Q'T@GP9SUK
MT@N'#%MHW:_1/8:1F^V.\UY1V%+!6;BJI0,?"_<I^@HM3,=B)U;S>$3,VX$Y
M(NYGA4_P#+JP:<V!M8DH<>S3"_O!TM;T(,<-'#XA?@S,HIN]I_2;YY%=Q,5@
MZ,/XC5^092T)O:8F7BL8\62ZL\W]XJ__J/^1*STLQ3J9BZ?1;7_FK_O,]U-H
MEI-/G 2"BMR:C^DTYORLX3=0I45_LBKGDZ^+CJN;MLL(!,$W.PUUOD.SD+3L
M@M*MP-<OI9^DFI=B%2:O)'%_E%57=M$J7NU(+W=TRVA6K_2BO<YSYW,A.L_I
MEUPQ1YA*D90Y9Y/(AK'!MT2-(T93*M-,@=&4_ZGA=0B?P")DM=^+YZ\0#@-7
MX;_&N^8H_+!WN1>\Y89AP5LB9SDJZFLI@RMG"N04PX@FEN!91!8EU9LW&X"K
MNR]"P5&>HJ:+4XW)[U20/^J9_:"LZ@3C)H24@BL3E(H*M:*P"!*M6%/1>IUA
M5T<V[T)9_::B%#XY1*6/*M:D5+U-TJ5&.6W?L+R& U>?WZUEO=JVU2/@(BWT
M#8UC9.JWQ+TLL0.0V('VV)CE"1-%--K_V*DE"H;EJ>XWT/I-Q)^X1=TGU1?^
MKIFDIE!<< N[GZFP+"D5MY?N@#IU-)AK\4/M&E#X/6LIZ7FT@_VJ*%<]O/1L
MQJO'%&L8*S ML3*"N8C]WMP.]=]YER8UHX2//F2:P!J7%9F4A?++&TR81Z)*
M-%G2!I2(:F <5?3)MI'J!?OAP1P'/9CCX<$</_9@CA[,L;%JX5%Z>E"7W LF
M1$QZ*V1#5F6?J^-=RM>45QA'IU^I-0[_/3;M<)UO@R-*Q#>ZU$K/7O;3/G;B
M*1@RXY;8Y1\U$;L<?YKJL:Z"(RJ^MXPR\&4[:><C+@H&\>=]#_*-:&>W[?WL
M_OOD[.KX#'O9C4Y/_ST<O']W<G5U?/1_M^:UOBEQ^M?63/N?[H[XYL._^^:(
MZ]?!=$3=IS>BJ6.TS1'[3GWKMA^_YTY]=_3GL\'JWHQ<_QZ3%GV.W/FAVO11
MF7$E_-&N9Q];GTLM^Q")^YD6=U^O91^SD=R'J+N7WO6KFT:7/%_!L/+IE<RZ
M 2_?2E<\5EU?U/RNH[< AU)@&%^JHQZX+1VS@BRH'P#EE5U7N4;W.7J&<%I)
M#GLU.SS%"681 4[M?*Z8,2YT-WI[.+ /69$I\FKFA?MBJ:=>\-=;ZIGY*!^B
MIUYP[Y9Z)IV.D%P&YPX'3%)K>@5(DT^;5N/>UB(+ZGYBL!-Y^&R^RXI>?GUS
MF0T8_M?IZ\=R\ 3:^M&+=G?ULZJ];^JW^=MBRW>U9[J^Z%M&;=KPK^YN&74O
M9?E7.T:):_Y--HSB#GKTIJY9E&\V-DG@1&?32=CLJ\3]G@)N(O45>TB1 ]'5
M1*JC?X!;=#E@/MM!BCH Q/=L\30<_.D>3W<:\4N#;G=X,H<A3S6MC _2US.N
M&L0"LSEB6.DP!GN[QOH%;G"0X&N&Q@MQ2%78FKP*JN1R(YK;!B?P"MN;LZ)M
MXSL*[K1S>SW[\."P%STX[.'!83_UX+ >'+:Q:N$QC./OFV0%7*5#A#:]@;Q^
MN#IS$0CGDI3UAT);O]3[2:PX5],?MCQO(;!FH^@.TT3Z32CU$0UJI"U@PX_N
M<K]:>VLIWR]H:JR.>T3[D*^]MS@V=OB>:J$V>&\UNB$@MKTZ67\:FA+"+DP.
M[EU4ZI+YQ5,-FUQXGBKR2<$GKB+LZF:6$!P39%W2B@F9)K7L<;^"TS0[7**Q
MB/JJSK6#EBS*;-M!9H?O_W5\-CJ[NMSR]_@&4&16X;]D2-(HCJF_91YXV/9>
M^:\;'O 6XTIYD.;2V4PR\M0N &W$8)SG'RF!BZD93M8JGR&OBPW08[@A\P^;
MRDD"&J0!%ST,DIH*G3/\<3H<&(J-8)K7A0$4X@7>J30OM,49"#4>CY9.I3D5
M8/IQ8)L.HQ9.,;97L)SXU&DA]-[#XAPC)-,JL>>;_Q:J$0ENX_7=VQT08K^+
M8TJRS=[[1'9+4+NN3[".F9)N#1^5])OE+A?P?B-#3?\&5X0NN^!%L12'_"9C
M^[TLFARS/%7<YJA0?E8<,YRJE&1:UP1&Z'2X9">S1DSJM -=P!WQB*0U^N38
MSJ(ZT5788B^3OEP8R&5L@X\*D=YY%'3EV[-W,ARL<$\DF-F\8XLLMO727&SO
MKX.T9UV:0^X.2R1?/C2%^@)8!^M.&J]N\Z=RO8!Q=KA!;QR5:HDTK=!4<)+7
ME06%&/\)@1/DBL$_D1R2WHIWB^&@E'(5=K^B2LJ+5U474T<M.V4D'"LFJBF5
MS)AFQ#(W?#4V"ZI0IZ"8+8MHT:%/N)YFC/WO2+QYNF0&YGG\46$6NA3@&0([
MJ/79CM>J)JJJO,C4PF9BN2/.&.[!A":L8_1L#&J'753I&0D3+HK.=-: D61J
M LIDUY<C>!B2[W<B;;@4B ?2V.RNEW3'+/I[._QK4]@?KNM$CPAY+JR1)9U&
M?A,B@Q1J*=$CV&C1-G )=E!X4,SA"$*0;T4=I'6)& ?1&WPQRNLNRE2A',4(
MR!+^*%;28U"RIH7/RHCI/H&(D=:ALX>Y(8.ZTJ"A# O):M'L96N=-#R&$8Q7
M-VLN+\L9:.TBYXA>MQ77J73Q4(ZJR%4=KK;FR+@G@P<L*YT*[FFNB\;QYN64
M"\>8S$-!?29MA<!^T[EADVH1H 4[U_J&6@0+8Z9T"&6[!R$#%9/CT#L)()%/
M:MQ&\F-XGQ3T-FX]C2?;SHOGN_"N[FS@(],T['& UK9)M(,?."S?!>EDTO+T
M?0.^%WR8P\L1E]"\L@K?&+%X(_MS:WMSGU>FF.4F;X*"8-2B6+G+)P"U^$JD
M@1/]BB2 (KX56<%R1HHQLTOCF"R$E][0>S!\"VYA)*C[:8V8T#Q:" *"NT"7
MB+.B<\\T'Y-W[#:OO#.;Z9:LK<GG.]QQEM_<\7N4"/!BI+L2"Y%4PU*'TZZ)
M=J@->42A;K2Z-792H>211/JTXKG<![;E G4]C$+VH(U1VJN4%U(8IGJ,YR/D
MP;_O\^ /GP???]XGPOM$^,;JA8>SL)*5UOM'I>;DC?I:OU#<<YQ.YVQ5T*O1
M[; +[[P<2:+H3S.4U!\6Z^S/B?'2R-BJ:.?H3V@0OA)+,H@FE91B2LBE20Y"
MAABU)')A0 FP>*EZPR#B8DOPU&OT$3F*X$>=&HC''3%6R1ZN&$F:PJ.2A;EG
MTFQWT Q?'NR])#F-QCE8)9QF;SH& AH5SU*7;9HZGXS3"VW=IT],+]?K[%?9
M%%+I335!D=MYN6L)L%?*^([S)1"B$B7J4W"Y*"N%M1LG6;P7[#A_R5S1:$XA
M>LXO,/D\5L3"ILF9T6CN@[@I<8IW%#@>&#]LYJ@I8&)'V>:Y;A/L2+ZCLK_P
M.F'3.;#<3BAH=A.BIDIC;V(PE*U@HB=>DZ0NNFUO,[$#TV?*-R:G277/[YO-
MC \[FAEC?<F'4O6)SG4G.H\CFRZDWM2E<]5-G@.=<8F!NAZYYJB"S_WU];/8
M[7B0N]-2. CT"083/A-02G092\)FZ0XA4JN6M6U^UD#7&1L#2W4I=\(Q)(K\
MN/;@'(#."TQRYJ@5J7K7ZQ/>ZB".!($8"1,3HM%'O)4VI5)M,I$;MBZ3:U<P
M=-@QY;0YP_*V".$CC4^<:51W:4TD.$CFI=_?1W[#[0XE%[QR><S3<2KNOI(+
M*V"1Q'PQ-8:&S;9I.;7L<MCK[<J<Y<7!L!S5KQ0U6TU8HH&\^LU7:@QQ.&@(
MFZ8#+*)>BU0@DU?R*F5>%S&GE2PXZ[6S_$C@:0+,A1C>Y?(2.7*HVM*.O<L?
ML1WW9M;,Q![6%.I=!+=(:8PU-IC=PL.YRE^;PWDI.^:_L:=))?",HM'Q(^Q-
MG6F>%A*G&(8+WA>]JLW1-NU@6PPO85$1.&Y-ZB+-)0AQC;4K7*93-(IWN&@G
MAHFKO*]R)$]Q1"DT0FSS05%MT&7P%HFFT;?7 8?7WN=.1,B6TF*MYRC#I9]S
M1*6D"4(@)I)5.1*"-II 3Y:3^^VGAK0QO-U&Y#*3"-]%35#:.;Q*>25<$M-O
M*\)7JB1[Q4P2.U(J"X8/6EI"T^_9-21^_L+[FH"V?M>VCVYR3:@(&P%VM]@+
MWLINI:L,[CC)ZW$54NR6]<J2U<KK,(?W:W346J$:EMJXMJFT[=HEN-\3PQ @
MA6JK][-EZM[:\W7;S8.QETYK[!X^* W@W/P5<H-?TP.O)"=81:43YD 4$RH4
MUOWMGJ!-/6O/"-O[[K/P>)/:(F^:TE:&?</")'S[0J#[)*)X%(*8UIFG4!(8
M'^6)L&F'QL=B%DEX6*8J379M"?[.:O4JY0.MY)UX9TT-UF!.$$ QUUHZL@4F
M&)'=:]VIQFR02FL"K5:< >Z!5/4H$T.;%&ZV<(0#G16__>9<9ZZ;?>30R+YL
M-_A5ER=M '^N*98A#S+?.)O76<(>^H+Q.=;^E9XOF&9N6BF*4[6$ZEMVWQ_R
M:'&US7'3Q82]8<U+&@*9@[#Y%JUNYS%"YNSAN6HDO92O/[! K!1OP<I$[8TM
M4 NT:/JJN[4'$,X-GM(&/94+*?#)BG9T;%&>Z<*W93U+FLQ<VHA"(Q253('6
M<3J:@QW.>%!EU#>0+6US<JG[TD\)DQ5;'DSFU< WVY/?]W+QM[K7"X^ 3WC9
MXQ,> 9^PW^,3>GS"QNJ%AW59VZGHZE:EF*_;/]@-9O"+:6>F[O/Y9S9X*SUC
M["/^MU&L$S1K=<)F\I#\PWL>A-;O<YS"="SZ%1O&#636&O3KA(H87B7^:.O<
MB<12;B($HC;\+5$_\&E#\^.D\>O$'P)^9QMUT' F8HW!Z4K<E2KA"/F-6I!M
M%EJ*3F2^M,2:.#/$ILP%.%*(0%>(41?ZQ$T2=;?O:I"Y&"IFHB:$&T2I\I\=
MMH@\[4B$D\I8&H;Q=-6B&$.D,AA>1HE:1()?F1(*"U^+5[,19W0DF5&!5@Q'
M*C!B*X'T3FI6ZK6W@L/+T!O,D*J 8<"P6NE")L.M@2FQP$(C'+?%27"XO;:(
M>/BN@4,([^KUUYM ZW>-ON?.2(F:93U__09X1 VUKWE=)LAAIR8J8YTZS5/X
MGZB8I7A>-,,P7M?R5OZ3KY.5IC3(.:>4&H@1/*8P9\A<)J&AQC=1&-K0,+"4
M]GC(*&_X#XSF6E$)1$;_H90HZ+LHQ2>$ML$E_/HVHF()0^Z&OR8*'!^M3F>5
MR;KPU[LP!=$,["*J1K!E:<1B#*^+Q]Q'3:>9 Y)TE:DUJ]J6T.I,I6H0\V2_
M47K.K(2T!79!S%W+^T+Q;"E;XZS0S ?HG-*4-2:[&4QM%2/FA1_@[KN K&M3
MZET,EB\,.Z.$ /T4/</XI(G+PHN:WI'8WMX)V?KU[%Y0#.9F$9I$D6\]F5[I
MN L-YDQ6MU_331D^I:9X48\_2=B?+$Q<0?N) Y8AIF%K7W;KU^IFUSA.U..[
ML6INC=AQ.-6F24"KELU]X8&EJ=_W;J!G<P*BU%@DV"C4%?YA9R0-!V/C<IDO
M";!2HCMFG!^E3.\.\/HPADQ.4^ACL4N+S5YJ9[YJW/XH6_7$2\,,A$N*V(+%
MF9I$.D6PAU-(G\F[NH27!\\9U^E'YVD3_2Z]"_),Q*F*R*=N4"%+8IJ]9[EG
M$^ZCZ-=I=-O7X&U I?S]/0D1(W(!K%6[Y #X1<(!&[5WF*YH//>VZS;9KJA;
M1')Z\W7CAO\ YJM;X.5E[0VC33!B$:$P:UJL6_M:V[XJ")6BEB;<>V'B$S8'
M)Y-&>!LL*$(Q46I$>Y$VTTNR#?_^GBH#6X&Z=HBN5>N O**)0L0!418QL#M#
MV%1585IDQ[>M&UD?&ODNM2#"ND=I;H[]!Z@,DL#A1/E 82_N>=&,>KGW\$K*
MV!!>&K48'F6^S(=!N;#;*?Q/^P'(<Y?7^/05D[)840$RAUO."4>:J#(N]!BO
M([O%IF,2)(](>;3,Q3K))1E%(4:[G,NO(IP299O&Q)"Q@!%4<$!=U+&0J^U@
MB@>;'#'FI"*CF-)/!&!F<&=CC1K]S)86KQ$];,/C&(Y*&:'E-V *$I)->EEV
M1L!ZNULV[UY;,^G^"OL+92*XEI$K[JKL67K+@#=;LT#GSR\KB*KO+'6_$,P+
M;0*WL-XR8CJ5<K8I;K,L(S!RJUZH.7>@-FAK.W P5;UPQ6&SAU=[TF1 GUF6
ME;AA>O&.^V&C%JIN21=$,OX'^*2QJ_8DA.^8 ,6VI*)9Q_R*BU5ZE^[A84NO
M>MC2(\"6#GK84@];VEB]\+"T*J"GEX[1'MZ\]MC+U9\XV\5FH H( I7A9F1R
M5;0CF@8$8:^*6)<<S%UT\^QU&83"1H'7[NP;HA6B:[.D>OBH5<99*-6+]4Q9
MH',=5Z;. RGBPA;R26AW.F>$\_ %FOZ&1]I$P>-I[E46-B'=R-PRKTQGO4[+
M+C2VG/<FPP&]BJL>#5WYZ"I;M[D>A'I"^$2LY]S4SJV0?7VJ"\5@:VD-RC82
M3T:R].[PTJ7*5IJK(7I/<-=E0(,MF!PC]&'E#<C7666NH[$LA>%,F=,2JGN(
M3M.I,<(HW(;H@*K4]HOVI$AFBR1E";1(,T6SFMVY4MB.VN,#7+Y]L/+N]Y?8
MKLKCY0$AH(]%8H:^DN9RQE)55:J6:+1Y!*XGKWD U2>TW(MD%P.!'(2XJU)7
MK]QQM  EJY3<L3H6=B>WI1>U6==B=-T\0SP.?$=IA?OMGZ[=TK$^68+H).;=
MS&\SLU*DCKC:K*T_\"JK0ZQK*)C)_GA<:QQ[Q?F(VZ9[RRR+Q)U*W+LG2R'Y
M^*V]:M1>E-PP:]Q2C$?:PW*^MFM@%BEL_?VPHYC8W%@0R6WGWQN*E!:;"U>7
M&)M*XD:-,7<9I=KC78M_%L9[<J@P&I1+VJ#[93!0$9'>FE&_\%4Q$\1"&Q Q
M["UBE;<?4Z(P=C1GBM6-.56X9'A2IZE8#5)X9:9)*E(I15\U*8\KDH*Y"2ZM
M..+.\A4J^0O4,0Z2%@.T,+?A$)Z&E8# QL*O6&I/+K]\J8>#%6O=>..E[62E
M@ XX4/>VG-5 ,7G_V'62;@9EGF+<BU#BF:JP?DZ F*"()>_+U;P=]HW,XI_9
M"U\X/\R*<>=>Z)7]>E-;5Y( T-9.C?-\KHHO, "D$S9'=^7'Q!"=FX)O#HE2
M,8XA03<@7\LC9 EW.C8+V[&V \P2#?52EY=4W4@<>)5-:6ILEKK4T#A<C3P.
M-9C5'*3E$HR,^K^YL+;M?0&G%8MXU"1-%6<@C3(;8);DD*+.C=9J[5D8UCU\
MHCX%;QHE&GM+&(P8.E>6TX0)Q$#G<M&P#?RC,$R*J$Y$2IN'D9^=:'D.T2[M
M1I?<L=T^AX/4@M,,5Y= @K@C_=V1C#8GET8+2KK8XZ YU^"*D,X+HC^+M.7)
MZBE+-Z4HB+J)GN49LVYIVU4N..*:1=*F7",IC0VD$'ZB)Z">=U[^<OGA_-=J
M^LMW^%_L-Y51]XBHL/::K9W,A"1(1$V:;I#KW0)!&OJM3*P6QP-FCH_;O##G
M/_5^:H=HJ#>6T ]A1TV,HRAZ>C<KT7"P8QA ;G2$>\ .A_:$K^UW0R$D66I(
M532:=HI&/L_3_%FJ/ZK@GSK#_;!S?OI/S U/]5@S>PIF=FE/4\X.OMX/#4(T
M*LL\UH1[Q<_)HLWIA>C/N3 $P]7\=:HSO$]0T2%05G6R(-(QS!$%53W+:8]/
M%9P3,*YKNG9&H@8NT8)FA%4+T1OZ186Q1TYL'FO%YH8-; T"&;FV62OHC'<P
MZ6$J$,%[\%+$A]X-WTBA;",]3   \0*G^:VZX=YA$47D2)^R_G2):YKFAG[K
MPMVR81O;IF;$"[T\EB:GGA"T44*ZR"-"R,;,P.0=R8P6H4<+UYGK&&AL&+"5
M9[AG)%IA U?^[;0-XF"D@UMG<+$5!HY"3%AC6B9WK3M6O47HFL/)D/CY.ETT
MN+:B[CE(<A/^-/QL5%:*0!1T)ZD[#"@-S.EAEYC_O>O#)ZB9H#!>R09OORD5
MHX7"0^6^Q%]TCL?-+#<E@P/N/IL3-HRW"SEB].7;9&]+CK%-3HO_T*?%'R$M
M_J)/B_=I\2=ES;Y":]98&2?4/%7WY%]K'?[;U0RRS=X>IK$C_E.6\)FI^-)F
M*2VU2+^>Z]]M/Q")_VT&YNU4SX,KJ2UC__'<($9=+VJ[[*NH1?%S0T.2V_M:
M-AGIY+S<,8+ER[6,P*83"<</.YL=$U%!M12C%'*;!J&."?:MNH_0*4MC%QR)
MEYGWB;.Q6=%L3O3M]!/SHKT@WV?XU@YZL-&#KSFZN#HY/#T>#OYU@B[F%K_)
MNY-+-*Q&9\?O/USN;?G+&+GZ6B_QF$KRU=X^*LDC-2'6?7 7>V-DC<,?@8*N
M2T,5W AEF]31\2<*",@!X0XO)OYL(5S<US,58;?2LJ^ 7=?P;0C1!O6\N.%P
M@ M4+E72N/!<Z-.G<<"N.U)L@FLIF3+F#ZKP"6TA)N$I\LP&XFPNTQ B\"-Z
M1;!^:;%8$Z)$\&0F8)'!#3]1L*91*JT%,PPKADR $%+79,:U8(P$!HRE7SX9
MQ(>,FN!<XN5(;K7#C5+ ?@V-F/AM/'89]L&150J&5H6*JH7P%F;\65XDU**&
MZ P3:;H2>BU70B8ZQB3*'W46\T<&_X%%5C%H/OJ9W[/)1O ][H=>2-<NI!V9
M$*/1*/=@ ^$3$^,V7;C?15D]P7(PF\VS21G\NB-,CI!>$T+AC#.%U$M//QJ>
M; 1_901:%8Y/0M51G5D^Z<5F[6)S*,G X> *LX$=N@V//\K1[P?FXH"N#>7S
M@Z7/,=-(7[UH?872\AWF3R,D6^>N?HC!'5-F!KO(B^,+UY:OO9Q?]P@Z1NN?
MMM,:YJ*=[J0\X"T5.I<PA%(J57TB&THW'\##]M[N7>P%+_8/]@[V=R)JUVH4
MN&O!5!II7AYO>V:^:+S#P;T'''2-=_S9\6ZO^'X[NX_"7</!4=,6#9SB3@A>
MD+F";MM<*X_CNNAI<S=@%=\=KCAUFQW,+359/%4S759HW<WLX:O\<BD,&HYG
MB(J5("4!%,^.+!;+'M$^NJNE UX0OFMWYX<>[+H!0N*945UN)T*JH^*CJLB#
MF.7H-R0H)'I,5.S($%=4"/GC_U)+1HH]JS1EY+K+BI1^[0X;9$MF'-/Y=@\P
M8I#7TB#C)5L0[;P;#G/[J! SCD8KY^Y+^:W)4^87IW_:5Z>_^.7QG\,!3P!]
M;-I2,BXC2I69!\(DRA!ZV=\$V1]KQB!CEQ]:ERY;J-G+WCH558"U'R#(F?*1
MSA&WQ82U+E1"T&B/[,;7D7O!45%?FWS-(KA1<):F"M%K4?)'?<,]>!DL'>NY
M)B.)NAM(:8'K-SFV7"5+3R_E;2PJ5V"(2.B/R,)".A*UA^&-(F0V:QD#E[?&
M^74&DTI]2J.LXZ41(!4C1IWKE?"P<.? ?Y4JKE[#!\_W7H!%"$=!L(,W K,Q
MH8(@ ;N)F8AAA1KC]8B5[#?.)FP<DN 5Y@7!1D^78*,G!K 68/\-:GXEMSQ/
M\^N<Z(G&H=E\\*UIOR&T.E@H0T6F$N@.#AD@[JER[-4'"A?W#7:D0(#J=)$4
MW&2CS-,;_M<\3Q>SO)A/\5/$(>:ZS&?<#+M8E%6$JIJ*OV;PT4Q5T3A/-?\4
M= 'LVA+C4 6X+M3\.C1!M)F$L$HBT>EC"8^#N?NQQ]P] N;N^QYSUV/N-E8O
M/,HIMJ(S=W<FI5W!ED151&F+J$A2"6'C%8T#R1P*6.:!U(<9)4[FVF0ZX#BY
M+J(9'3+3'.MF*Q5/,PV;C[Z,"?*N*7O":1?TT6-*Z$P7I8"[N6[.?1E@ZRAV
MWO/".#A,.PC32C>N\@K4 7Q41)@%QH,PPMIF.B?K(E9H<V%VQD;HL5[/^S.?
MH[]39W3C&-8)#U JL*#\8*;2(-4EVXX32OAP58=IC,VM+;E6E_#Z4MI8-,L;
MR+-BM@DL<)?&NG*X<O2I3UROLQ<0> -LS@DTCFDH7?7=W'1/-<PKW&0.0XBZ
MC"5F*(0QR+E2(E6.+J=,/"G]3/,BRE1>EYC#QI0BAI]L!3X5PF[O+&Z[$(Q9
M"&0U5;)*$-HTHKS<6 ^5Q;8;4?M7TA6IO+\@@,*XG>;HI#*<(<M;7):M3MIF
MN&UI7 )<D)?</@3P43;_3:1!D=>0:6;[_<K=02-O[TIONZ#&+*B@C<8@*OCC
M>2VJ9ED6(RM76!/JG3ETH%VK#%$5((6L^R2F4A5(7VYXLD#R)I'7#,.*MC"H
M]$3F:R8DU"45I<\QZ)0A/BIA!,)*;>0(<T O@"FR2G=8K>6;F(%G88;X #:4
M2F3+ON$FJT*YP**&W5L>14/V(8EU83@Q/-7E1IB@<F)IZ[JZ]'#X>393"1K&
MJ6=:F=2K*VM=+7JN]9L4CK,XHQ<CQ-O8.5=@!<2V/,YOU*XI;!<6'5,38PLC
M&N%HK[SVKF%P@U9KX-/[25U-1ZM(P\8"M\IJXE)<IFO#H7>>TS3+)DEI>]%2
M]ZVZ:I)(8WW(/I%<\N2ZXQWO3C<34X<?M?(-<?-^PBXFN!?GR(5/>=,N.HI^
M2VY"- ".[T8"R,2TT?,T.I2JJV&A4]@Q>/Z/-7-+Q/)SK[=)Z/5P#H6F3!H:
M>]RH) Z&6L7!<*4?"M?A#P=91-Z\A\TDWC%XLU3'Q*H98B5[=1U1B],LIV#U
M=8V]L2IJ=%JBK6,NA3_,@#'F+7U9/*9%+%7G?M.^K8P]5^7EX&?YG*%29 =S
M<QZMRCZIOR&RG*<-46[U>/.@;DQ34 9+OT^5G^%9RLM;+'FCXP-MF; 3KJ[!
M/B%FCO.HHGWP3S">G_V6WX8.Q8N\$,2P43,1%.C-:F'XA5%YT\8+(JECHX 1
MJ_\=0Y."C0)L"1Y\+6(?>GE8XNN+S#<"]C-_7=.>29;;)UAUO2M8T\Z(%6$F
MZ![&/!3</%WM'U=4T2'G%4P-9SW=<+TA412/3$._]X'0A5C?E.YACO0;G1LP
M WHF5 -B&J/YW9=H<,B2!R.^YD]I[=K49M@EY),N*TH*1*5Q:BJ027[\JME@
MC.!$@Y)K5!8Z,D(S7])YPILMNK&=$)X"3UAH(GM]LWY]<_&VZ]A$<PW3OX7"
MN"VG4QL8FP8:8GOGX=M9QO>KEE&,!=3H*BJPI5MQ'66"MF)8EX$4K[B$K'NR
MV$&EHR@P[R52%<H'9$:9NR#]$T*RT!X?*S#])U[/ZF4EXZ$8>Z':A.$[H;J\
M6"54_EHO1$OT"F+SAF_74BIT&NL)>W'I K0BEI.H":/=')&50U[Z.5/8SI6D
M0YM7(W5U9<@?\2IRF**RC, Q:5\9P<TJ__?(W?!)QTB)M0A]K$X8_*?F3 "R
M\%,AT'?F$U,$V;@/YC#!$-)</!>EBU*C$V7K(T1U8<HW_AA=XSLU?E\X%HAH
M,HET(?@A)E-3\ZB0<4V((X*^ YNO1(H'B9R<G!VQW_5N-.KC>8\ ,?JIAQ@]
M L3H90\QZB%&&ZL7'N/ O'SW9@5(]@@CTI?11$EGH7=YAMA85/AO<@S&1_-Y
MKBD0T2ZNZ17^!BSLAU5FK4_5*>O[84[E<A=BX;H:*C%QWQZ-^D7>F.';13X^
M7%6V[J.4;".'LE_#C1F^74/86BO6L$%N$;S-<^85H)J<43(#:[ZLI'.#5*.4
M-04@N4.-YF NYNG[95[[,OLD=\.!8;E;=/,&9'95K^W/0M- J4V2 MX:U749
MNA0;?)YC20C'+^IQHKEKAT,)4=JNK.>%=+F@G[J &-%DX].I#)Z>)6X@CH/E
M"P&[6/'D)1#+DM$C-5C!->8:P8!&))UY8?@*C0>\NI9R3!T3OAG'C7\@L4J"
MZ"<8NU>);YLTH@'"=(+Z1A'OBN;Y\-Q6W _>#KE12%0OS!KP7@P"KB*=21C'
M37._5=:^57Y345I-AX-##+VV>(,88X$[A4P9KYL57-@,S<WA7VCBQ)&4B#--
MQ)3NSL$:,GX:<'C+F-ZD+FJ*R\]>>QP.)8>M0(Z)_0B7/VV)F4\7$_KENX:O
MTJ_>9>P]2#;'5ZAJC'L28G$7#1]Q-KB[X=&P:YHAJL[C(^2S@\EIRAD\/2ZQ
M.SO!N*2T4;9XFMJ(-;(?E3[]D7""7M<:2S(S_'+Y>>>4&PQX+7'1<8SXL'O<
M/VC?GDI,+1%'>W%X2S-[CI.'5:RBKUTK(6D.<!/%[.%@ (M3MA,C/<\87,#=
M6D1T2* \_$Z(F*G5,R]3<)))["XX!QO;1 F)7#6FXE'S$<X1#&#_IY]>!3O?
M'P0?]B[W#O>"_1<'SV$6*ACE?_9V5\SB<+!Z&FU-PLK9#+YX,GMMN79M>;+*
M?S_);E -7>.):#&8;XH\GB)0I_<$-F7X;B4/5R6I6=FP*T<-_$RF&H&V#+QU
MB4>'B<#TY,3/?)J<9;_XFS)\M_COSCN!?51:Q]N8;70Z]77&X",T+OK%6__B
MG1UU+]Y):_'PYNR_\]GJM]UJ6@W4UY4/6O''+.4+4\OQXI/IEB %LF'>50WS
M*,43'0_\MEW@\;A+@*^7H_7+$5C@8Q"")3[*U=RZ!LX86? < =[045"(J1/Z
M& >[2VHK>:W6A> "H!T*O_V9X/5\\K@1L8M.IJ%7L(:".LZ+(K\%><+FMN!0
M$2J_]>M6]5)&/=VQ?#?'?E1P'9QK8)@XE+ +9.!-/*@RC8,^<P:[8U?U(<T[
M,8_##7>9IIAARCY;8*N[P!BI:.:Z(@*JI,$GB^8V5JPPRPP7$2MS1Q^=^??1
MZ!R&D^S*'&-#=<U=RK!9:U$PFI-[.LX+Z9AMT:7$SD0>5!GL^&0]5,XUCQ:X
MV<4MXW[1<5&CN<#CYO[NB<;Y+8V68);;@CJ]%]P5S91.[WJN9&B-A>@FU\R5
M@\*5UV,)28$#G(%@(6A;JC8$W#W-TV0<Q1]+?WG\I? P47/D*?+:E,'/=]1N
MXVJ&8E(0C.%83-&+)8M-"4")@K]Q.A:P&%C53F652/Q386B*ZBE4A-UO<;[S
M++5%EM(W XO.*?Z&;0-AA#LXLX@]ITZ;1,J:I@U1H)J+*>@/E>P:2B2>01Z'
M_R8ZLP((XX+WHJ?Q2$M_J#N39?EM=(LV8/RP.9;F _#Q=88CQY)Y$Z,#1WCG
M>OGVM*5XC^YP\,UC4,05Y<F4&A9O>T^99XD@N#@^041S.<RUC^7%(894?@I;
MRSV/>^:=:JQAR)SL>TT:[6EE*,K@%:;+KV!8PC/+>&4HSF3K:.Q4;CL;^S4#
MS0"2M_U,=[V[!Z-E,+ ;3"M:?V!8N%##7A<$$-GT!;GBU8*GMB3&7[BK1M&;
M1S&C?FBZVW$J7M(  [N@5Y.2^W*Z^%%IL@)RX8Q:&!I4=93<Z!)#I1-LFNSV
MEKMJ.+ ZQ]M<WEQ9%':CG:>3$7XQVTBQ]/"1M@GTW1-*@:^=/SZOQ%W\%N^H
M<?9C9;@K2O>XLA[_(3^)P32RVHD% ]X]X?@Q@IP6_)8&M4^G#JH 9MHEN#K>
M$N;[^EJ1 C?5;HY^M'4*[X*,?-SM+CWP]Q*!]Y'^PF.6XA(PKGX#,8$#FDK
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M',*C)GF1@0K_Z?O]_7U*!8RV=^6:?D/Q,3A5ZG5PI,9CK8)_IKK<VC?;<KV
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M7,\"!MQL7!>E<C%VN7SBB(I+:D4CU,[$S=N\E*MJN,_U,OMOPW"ML]28_*[
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M,\HGH'2R5J,MD3@1:8XEHJB^L0I3XA<[.>FIF'YV(3%QS)H\4\] C\5 0\U
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M.;K9/4>8_]Q"F)%N0&B%XXAEH1%F] OY^:B2F0%#N(2:X"T8B\^U58U3L(!
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M$#*V+ZBN]I"1&(/ I\J07IZ%,5;ER8DX4E<J@G7")E!1YO/G@=B[4G&NQ*M
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ME=OK3GYAGQMQPV@F_U7FKOR5P^W.:CCR(!F-0L)*9 A >^4-XVL_._>XA$_
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MN;J5J@.7)?CB1Z>K6BY=5@YKA^5J;/ML%Y5O2@?;9_ME5#H_/3VL5@_/SY:
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M&R])YR8 N?=DZ@DT5D2KA<,T^V=NN;V$WKS"<I@9,)H),)DI,([&]!;_1"K
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MO>_KOJ[U7'R[6 ?<-#$T-@1045$!_N>X6 ;<_V_V?S7^.^3_]@RJBX\ EFL
M(. 3-94(X H+%34+U04&( 0 4-'\/QL _^^@ND)]E8:6[AK]=8;+#1TW 5>H
MJ*FO7*6FH;EZ]7(U^G(=<)6%AO66TEU:-DMW.I%@=N68[(IKHO=:4!Q64P0Q
M%8^06/KKG%S</+SB$I*WI:15U=0U-+6T[_]C8&CTP-C$VL;6SM[!T<GSB9>W
MCR_8+S0L_%D$-/)Y7'Q"8E)R2FI.[JN\_(+7A45O*JNJ:VKKZAM:V]H[.KO>
M=_<,HC%#PR.?1L>F9V;GYA>^+2YA<?B-S:WM'SN[Q)_'OTY.?Y/^_/T/%Q6
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MXM.B(;:S'EV9/,T;)=JR3,184C #-P5S>14;5_B7+J$V^6SW,^ 71+O5+L-
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MX?WSAK=@D\5W.T=YH\(MM>@2?KS!F::3W$PZX@IP'0>Y)N"Q<.JR,'6E77V
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M4FQ^I]TY<_R\_ZMS,5A@GDN;>GV>)PRX7G)&EUH1B^G3!Q=ZO3=^W/+M8?^
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M,C R-3$P,#8N>'-D4$L! A0#%     @ #TA'6U!J+\CV"   :6@  !4
M         ( !\0,  &)G;7,M,C R-3$P,#9?9&5F+GAM;%!+ 0(4 Q0    (
M  ](1UL4\J"AX@L  -&/   5              "  1H-  !B9VUS+3(P,C4Q
M,# V7VQA8BYX;6Q02P$"% ,4    "  /2$=;&'M"$$ (   #8P  %0
M        @ $O&0  8F=M<RTR,#(U,3 P-E]P<F4N>&UL4$L! A0#%     @
M#TA'6X$QJW[[B0  7]T$  D              ( !HB$  &5X,BTQ+FAT;5!+
M 0(4 Q0    (  ](1ULOI0HOLQ8  %"P   +              "  <2K  !F
M;W)M."UK+FAT;5!+ 0(4 Q0    (  ](1UO0J<D"@#0  (TU   /
M      "  :#"  !F;W)M."UK7S P,2YJ<&=02P4&      < !P"U 0  3?<
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BGMS="http://bgmsglobal.com/20251006"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bgms-20251006.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
        </entity>
        <period>
            <startDate>2025-10-06</startDate>
            <endDate>2025-10-06</endDate>
        </period>
    </context>
    <context id="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BGMS:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-06</startDate>
            <endDate>2025-10-06</endDate>
        </period>
    </context>
    <context id="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BGMS:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-06</startDate>
            <endDate>2025-10-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-06" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-06" id="Fact000004">0001130166</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-06" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-06" id="Fact000010">2025-10-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-06" id="Fact000011">Bio Green Med Solution, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-06" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-06" id="Fact000013">0-50626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-06" id="Fact000014">91-1707622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-06" id="Fact000015">Level 10, Tower 11,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-10-06" id="Fact000016">Avenue 5, No. 8</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-10-06" id="Fact000017">Jalan Kerinchi</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-06" id="Fact000018">Kuala Lumpur</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="AsOf2025-10-06" id="Fact000019">MY</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-06" id="Fact000020">59200</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-06" id="Fact000021">(908)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-06" id="Fact000022">517-7330</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-06" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-06" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-06" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-06" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000027">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000028">BGMS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-10-062025-10-06_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember"
      id="Fact000030">Preferred     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember"
      id="Fact000031">BGMSP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-10-062025-10-06_custom_PreferredStock0.001ParValueMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-06" id="Fact000033">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
